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ABSTRACT

Su, Yuan. Ph.D., Purdue University, May 2016. Direct Drug Monitoring And Lipid
Profiling Using Ambient Mass Spectrometry. Major Professor: Zheng Ouyang.

Mass spectrometry (MS) stands in an outstanding position in analysis of biological
specimens owing to its abundant structural information, high accuracy, incomparable
sensitivity, high speed, and the large variety of its applications. The ion source, an
instrumental part for converting the analyte into ions, has played an important role in
analyzing biological specimens by MS. However, the performance of conventional spraybased ionization methods always suffers from chemical interferences derived from
complex biological matrices. A series of sample extraction, purification, and separation
steps is required before the ionization, so as to ensure excellent performance of MS analysis.
In order to simplify the MS procedure, ambient mass spectrometry (AMS) was developed,
where the analyte can be directly sampled and ionized from complex biological matrices
without or with minimal sample preparation. It is beneficial if the developed methods can
be appropriately used in wide applications. At the same time, the simple procedure is
complicated by declining qualitative and quantitative performance. The goal of the present
research is to develop and improve spray-based AMS methods to meet real applications.
Three problems need to be solved to meet with the aim: (1) How to collect and process the
sample according to its physical and chemical characterizations. (2) How to effectively

xxix
extract and ionize the target analyte with reduction of matrix effect. (3) How to produce
sufficient and accurate structural and quantitative information on the mass spectrum. In
this study, paper spray as a new spray-base AMS method has been used for two applications:
(1) Direct drug abuse monitoring for forensic and therapeutic use and (2) Quick screening
of antibiotics in food for the food safety. In addition to selecting proper paper substrates
and solvents, the quantitative performance of paper spray has also been enhanced by
treating the paper substrate with oxidation reagent.
Moreover, pipette spray was developed as a very sensitive ionization cartridge by
integrating the paper-based extraction function with the nano-ESI ion source for direct
identification and quantitation of drugs in complex biofluids. Internal standards can be
preloaded in accurately confined area on the paper substrate, so that excellent LOQ was
achieved for analyzing antimicrobials in milk and abused drug in whole blood.
Finally, to the best of the author’s knowledge, the isomeric structures of unsaturated
lipids from tissue samples, were first directly determined with systematic structure profiles
by the AMS, which was implemented by extraction spray and on-line Paternò–Büchi (PB)
reaction. C=C double positions of target unsaturated lipids can be determined according to
their unique fingerprint fragments derived from the PB reaction. The small sample
consumption of the extraction spray also enables the profiling of spatial distributions of
their isomeric ratios in tissues.

1

INTRODUCTION

1.1

Mass spectrometry for drug monitoring and lipid profiling in biological specimen
Biological specimens are small portions of materials taken from participants by a

biorepository for research.1 They include different kinds of biofluids, such as blood, urine,
saliva, tears, and lymph as well as solid tissues. Each kind of biofluid is a society
comprising of billions of molecules with quite different molecular weights (MW), sizes,
structures, polarities, function groups, synthetic pathways, and biological functions.
Analysis of these molecules offers key information to reveal situations and
relationships within living organisms and has played important roles in clinical diagnosis,2
biological mechanism study,3 quality control of pharmaceutical products,4 forensic
analysis,5 food safety,6 therapeutic drug monitoring,7 and so forth. For example, lipids are
a group of naturally occurring molecules those are widely distributed in the whole body of
animals or plants. They display very important physical-chemical properties in cell
membrane development, energy production and storage, hormone production, and cellular
signaling process through their self-assembly and collective behavior.8 Many studies have
shown that distributions of lipids are closely related to the biological function and the
disease state of a tissue by affecting the membrane permeability, trans-membrane structure,
and enzymatic action.9 However, comprehensive elucidation of lipid structures is still a big
challenge based on current analytical techniques that renders slow progress in
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understanding collective behaviors of lipids and their biological impacts. Many researchers
are currently working to profile the structure of lipids and determine their concentrations
in biofluids and tissues.
In addition, drugs are another important family of molecules to be carefully monitored
in the biological specimen. Take therapeutic drug monitoring (TDM) as an example. Each
therapeutic drug needs to be cautiously prescribed with a dosage within a therapeutic range
to achieve maximum efficacy and minimum toxicity. An overdose may lead to
development of organic damages,10 or even to death from poisoning.11 However, the
therapeutic range of a drug is not only determined by drug’s chemical or physical properties,
but is also directly influenced by many patient-related factors.12 Some of these patientrelated factors can be predicted through investigations, but many others are unpredictable
with various symptoms from patient to patient.13 Therefore, the concept of “make medicine
personal” is proposed to adjust the drug dosage to fit for each patient’s health situation.14
At the same time, TDM is developed to assist meeting this therapeutic objective.15
Typically, blood is most commonly selected for TDM because it reflects in situ drug
concentration, degradation, and hydrolysis in the circulatory system with time.16 In
addition, the drug concentration in tissue should also be measured and imaged to evaluate
the drug’s performance in penetration and treatment of the disease tissue.17 In fact,
therapeutic drugs are only a small portion in the drug family. Techniques for drug
monitoring have many more applications, including drug abuse monitoring in biofluids for
forensic use and clinical treatment,18 antibiotic/pesticide monitoring for food safety,19 and
additive monitoring in cosmetics for skin safety.20
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Generally, many instruments and methods have been developed for the analysis of
molecules in the biological specimen. For drug monitoring, immunoassay is most
commonly used in combination with fluorescence,21 ultraviolet-visible absorption,22 or
chemiluminescence.23 The mechanism of immunoassay is based on immune complexation
between antigen and its antibody with specific binding sites. An accurate and quick test
can be automatically completed with minimal sample preparation. However, immunoassay
is not applicable to all the drugs for lack of the corresponding antibody. The unspecific
binding between antigen and antibody diminishes the reliability of this method with false
positive or negative results. Chromatography techniques, such as gas chromatography (GC)
with chemical specific detection method as well as liquid chromatography (LC) with
florescence or UV detection, also show excellent performance in analysis of non-polar or
polar molecules from complex biological matrix with proper sample preparations.24
However, the detector should be carefully selected if more detailed structural information
of the analyte is needed.
Mass spectrometry (MS) performance is excellent in providing abundant molecular
structural information in high sensitivity, high specificity, and high accuracy with a broad
dynamic range. In MS, charged molecular ions with various mass-to-charge ratios (m/z)
are generated from an ion source, and then delivered into mass spectrometer for
measurement of both m/z values and their corresponding ion intensity. More structural
information of target molecules can be obtained from fragments induced by tandem mass
spectrometry. Therefore, MS provides an alternative strategy for qualitative and
quantitative analysis of biological specimen. Due to the great complexity of the biological
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specimen, many MS-based techniques are still under development for better performance
and wider applications.
In this chapter, a critical review will be presented with focus on MS-base techniques
for drug monitoring and lipid profiling in biological specimens. The review will follow the
conventional procedure of sample analysis, including (1) sample preparation before MS
analysis and (2) MS for analyte detection.

1.1.1

Sample preparation before mass spectrometry analysis

1.1.1.1 Sample collection
Sample collection is an important step in biological specimen tests for its significant
impact in the accuracy, precision, and sensitivity of the test results.25 In addition, poor
sample collection may also result in decreased ability to identify and manage infections,
higher cost and longer waiting time for patients, as well as discomfort for patients from
collection techniques which are too invasive.26 Many protocols have been developed
according to the state of the sample, viz. biofluid or tissue, to achieve good performance of
the test with minimal sample consumption. Clear instructions should be provided,
including sterilization before sample collection, timing and location of sampling, specific
container to be used, volume of sample, as well as storage and transport of specimen to
laboratory.27 Typically, collecting tube and dried blood spot (DBS) are most frequently
used for collecting biofluidic sample, while biopsy is the main method for tissue analysis.

5
(1) For Biofluids
Biofluids include blood, urine, plasma/serum, tear, saliva, lymph, and other liquids of
the body. Each kind of biofluid shows individual strength and weakness in analysis based
on different characteristic properties (Table 1.1). Some biofluids, such as tears, urine, and
saliva, are easily obtained by directly collecting them in the tube. However, contamination
during the collection needs to be avoided. At the same time, blood collection is most often
used for its in vivo diagnosis of patient’s health with accurate and abundant information.

Table 1.1 Characteristic properties of biofluids28
Plasma/
Blood
Urine
Saliva
Tear
serum
Density (g/mL)
1.05
1.01
1.01
1.00
1.17
5.17pH
7.36
4.5-8
7.32
7.00
6.77
Water
Total protein (mg/mL)
Total lipid (mg/mL)

Lymph
1.01
>7.0

55-60%

~95%

90-95%

99.5%

99.5%

-

64-83

0.5-1.0

65.5

2.62

6-10

29-41

4.5

-

5.7-8.2

2.8

0.06

0.481.02

In the process of collection, many parameters need to be carefully considered. For
example, since concentration levels of biomarkers vary from minute to minute or hour to
hour, sample collections in multiple time-points are needed to reflect the true time course
of drug in-take and development of outcome.29 In addition, multiple time-points of sample
collection may cause inconvenience by requiring extra effort on the study team. Therefore,
it is necessary to establish an efficient and balanced plan of sample collection.
Furthermore, different equipment has been developed for various purposes of sample
collection, storage and transportation.27 In the beginning, biofluids were filled in individual
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capped tubes with manual labeling, which potentially led to operational mistakes. In order
to reduce the chance of human error or cross-contamination, an automatic system was
developed that incorporated biological specimen collection, preparation, and MS analysis
in high-throughput.30
In addition, biofluids undergo inevitable degradation or hydrolysis under reactions
with enzymes and other chemicals, whose reaction rates are obviously affected by
temperature, which is an important factor to be considered in the process of sample
collection, storage, and processing. For example, urine should be promptly transferred to a
refrigerator or an ice box before test, so as not to disturb concentration levels of metabolites.
Live cells can live in room temperature for up to two days but must be cultured in liquid
nitrogen at -150 oC to keep alive,31 while the storage of plasma requires -80oC to remain
intact. Anticoagulants and stabilizing agents are also added to maintain the stability of a
certain biomarker.32
In the 1960s, dried urine/blood spots (DBS) were first proposed to address problems
in collections, storage, and shipment of biofluids.33 Applications of DBS became
increasingly popular later on, since levels of biomarkers were found to be more stable in
blood than in urine. Typically, the DBS method involves applying small blood samples
collected via a finger prick to commercially available paper cards pretreated to prevent
sample degradation or contamination. After drying in the room temperature and
transportation to a laboratory, the blood spot was extracted and analyzed by a mass
spectrometer. This process can be either fully or semi-automated.34 Compared with storage
of aqueous blood in tubes, DBS shows many advantages in collection, storage, and
shipment of blood samples: (1) The stability of drugs with DBS was obviously improved
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by suppressing hydrolytic enzymes in solid DBS.35 (2) In addition to higher accuracy and
precision, DBS also makes storage and shipment of biological specimens easier and
cheaper. There is no need to prepare a freezer or an ice box for storage or shipment. The
biohazard problem is also less serious. (3) DBS is a less invasive method with lower blood
requirement (less than 50 μL) compared to conventional blood collection (~500 μL). As a
result, blood can be obtained from a finger prick or a heel instead of venipuncture. It is
especially advantageous for blood collection from infants or children. Benefiting from all
the advantages mentioned above, DBS has captured increasing attention. The combination
of DBS and MS analysis has become a standard method for therapeutic drug monitoring
and the diagnosis of inherited disorders of metabolism.36
(A)

(B)

Figure 1.1 Dried blood spot sampling (A) Comparison of conventional blood collection
in individual capped tube and DBS sampling, resulting in ease of storage and a 100-fold
decrease in blood consumption37 (B) Photograph of commercial DBS card for clinical use

(2) For Tissues
Tissue is a solid group of similar cells from the same organ that collectively carries out
a specific function. The compositions and characteristics of tissues vary with organs, so
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different sample collection methods have been developed based on the nature of the target
tissue and the purpose for the test.
For the in vitro tissue analysis, tissue is directly sampled from organs excised by
surgery and then is stored in capped tubes with individual labels. However, oxidative attack
and hydrolysis damage continue with time that may change concentration levels of
biomarkers in the tissue. For instance, the half-life of RNA polymerase I in a rat liver is
only 1.3 hours, while arginase can be kept stably for 4-5 days in the same tissue in the room
temperature.38 As a result, the turnover of muscle proteins shows a problem due to different
half-lives. In order to minimize the processes of degradation or denaturation, many efforts
must be made to keep the tissue in low temperatures, remove oxygen, exclude light and
other radiation, and sterilize against micro-organisms. These goals are achieved by freezing,
addition of preservative fluids, and storage in the darkness.

(A)

(B)
Sheath
Tissue
Needle with slot for specimen

Push the needle into the tissue

Slide sheath over needle to cut specimen

Withdraw needle, sheath and specimen

Figure 1.2 Needle biopsy (A) Photographs of ultrasound-guided fine needle capillary
biopsy with corresponding sonogram of a needle positioned for biopsy of a large neck
mass39 (B) Principle of needle biopsy for tissue sampling

For the in vivo tissue analysis, the sample collection requires less invasive methods
with lower sample consumption. In the 1930s, needle aspiration biopsy was developed for
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investigating superficial masses or lumps.40 In this method, a thin and hollow needle is
inserted into the target area of the body with assistance from computed tomography (CT)
or ultrasound scan, and aspirates the tissue sample inside the needle. Then, the fine-needle
capillary sampling biopsy technique was developed without any aspiration, which
simplified the instrumentation and manipulation.39 The collected tissue is then transferred
to a laboratory for chemical analysis. This method has been widely used in the diagnosis
of cancer and inflammatory conditions.41 Compared with an open surgical biopsy, needle
aspiration biopsy is safer and less traumatic with only bruising or soreness.

(A)

(B)

Figure 1.3 Tissue microarray manufacturing and applications42 (A) Procedures of
preparing tissue microarray (B) Photograph of a haematoxylin-eosin (H&E) stained
TMA section. The diameter of each tissue spot is 0.6 mm

In addition, the development of tissue microarray enables high-throughput tissue
analysis with little sample consumptions.43 It is especially beneficial to discovery of new
drugs for cancer treatment.42 Typically, small tissue cylinders in a diameter of 0.6 mm are
taken from tumor tissues by needle aspiration biopsy and then assembled in an array for
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analysis.44 Early concerns about tissue sampling in a small size lies in false negative results
from missing problematic cells.45 However, comprehensive studies have demonstrated
good concordances of 99.5% between sampling in large and small sections with five
replicates of tumors in the prostate,46 breast,47 kidney,48 stomach44b and brain.49

1.1.1.2 Sample preparation and purification
Sample preparation and purification is a series of processes aiming to isolate one or
several molecules from complex matrices (like tissues, biofluids, and cells). The analytical
performance, such as limit of detection (LOD), limit of quantitation (LOQ), or sensitivity,
can be significantly improved with appropriate sample preparations. Isolation methods
were developed based on the differences between the target molecule and the matrix
including solubility in the solvent, binding affinity, polarity, and biological activity.
(1) Liquid-liquid extraction
Liquid-liquid extraction isolates target molecules depending on their solubility in two
immiscible solvent systems. Typically, the original sample is added with an immiscible
extraction solvent with a higher solubility of the target molecules than the matrix. After
sufficient mixing and waiting period, two layers of solvent are formed and the target
molecules are transferred to the extraction solvent. After collection and concentration, the
extract is reconstituted with compatible solvent in a proper concentration for MS analysis.
Liquid-liquid extraction has been widely used in extraction of lipids from tissues or
biofluids. Many efforts have been done to improve the extraction efficiency by optimizing
procedures and the formulation of solvent. In 1914, fatty acids and cholesterol were
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successfully extracted from blood or blood plasma by Bloor et al.50 However, lipids are not
stable in a high temperature. The process of extraction also consumes a lot of time. In 1959,
Bligh and Dyer reported a simple and rapid extraction method that has become a standard
procedure of lipid extraction from the tissue sample.51 Generally, the tissue was first
homogenized with a mixture of methanol and chloroform to form a miscible system with
the water in the tissue. With addition of chloroform and water, two layers were formed: a
chloroform layer with all the lipids and a methanol layer with all the non-lipids. In addition,
the protocol for one-step extraction of fatty acids in plants was also developed with a
complex solvent mixture.52 Methanol and H2SO4 were found essential for transmethylation
before GC analysis and heptane for extraction. An additional solvent like benzene or
toluene helped to dissolve non-polar lipids. However, the toxicity of the extraction solvent
is still a big concern for the health of biochemists and environmental protection. In order
to reduce the toxicity, an improved extraction solvent consisting of hexane and isopropanol
was formulated, followed by removing non-lipid contaminants and washing the extract
with sodium sulfate.53
In addition, liquid-liquid extraction is extremely useful in therapeutic drug monitoring
by extracting drugs from complex biological matrices. For example, Charlotte et al.
successfully monitored the eleven most commonly prescribed nontricyclic antidepressants
and two metabolites after liquid-liquid extraction of drugs from human plasma.54
Additionally, a single HPLC assay was developed for monitoring five HIV protease
inhibitors (indinavir, amprenavir, saquinavir, ritonavir, and nelfinavir) and a nonnucleoside reverse transcriptase inhibitor (nevirapine) in human plasma with the assistance
of liquid-liquid extraction.55 Through the extraction, this method was also applied in
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pharmacokinetic studies in non-steroidal anti-inflammatory drugs by Sultan et al..
Piroxicam, naproxen, tolmetin, diclofenac, ibuprofen, and other drugs were separated from
biological specimens like plasma, blood and erythrocytes, and were subsequently analyzed
by liquid chromatography-mass spectrometry (LC-MS).56

Figure 1.4 Direct mass spectrometry analysis of biofluid samples using slug-flow
microextraction nano-electrospray ionization58

In 2005, a liquid-phase micro-extraction technique was developed, which simplified
the extraction procedure to one step and reduced the solvent consumption to 15-20 μL.57
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In this method, a porous hollow fiber was used as a sampling probe and was pre-filled with
the extraction solvent. When the probe was inserted into a biofluid, target drugs were
directly transferred to the probe due to their higher partition coefficients in the extraction
solvent. Biofluidic sample of 100 μL-4 mL and 45 minutes were required to complete the
whole procedure. Recently, Ouyang et al. further reduced the sample consumption and the
operation time of liquid-liquid extraction through slug-flow microextraction nanoelectrospray ionization technique.58 Five microliters blood or urine sample was directly
injected in a nanospray tip that was preloaded with the organic solvent. The extraction and
ionization of drugs for the MS analysis can be achieved in an integrated device within 3
minutes.

(2) Solid phase extraction
Solid phase extraction (SPE) isolates and concentrates analytes from a liquid sample
based on their higher affinity to the stationary phase. Compared to liquid-liquid extraction,
SPE has higher recovery and higher separation efficiency. More importantly, SPE
significantly reduces the consumption of organic solvent, so it is less toxic and more
environment-friendly. Benefiting from the mentioned advantages, SPE has been widely
used for purifications of biological specimens. Generally, both the target molecules and the
impurities were retained on the stationary phase when the sample was loaded on the SPE
tube. Then, impurities, target molecules, and the other strongly retained impurities were
sequentially eluted with applications of different elution solvents (Figure 1.5). Three types
of SPE stationary phases, those being normal phase SPE, reversed phase SPE, and ion
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exchange SPE, were developed to purify molecules based on their different structural
properties.
Normal phase SPE is generally used for extracting polar molecules from a mid- to
nonpolar matrix by a polar stationary phase. The interaction between the target molecule
with the stationary phase is mainly caused by hydrogen bonding, dipole-induced dipole
interactions, and dipole-dipole interactions. Silica particles are modified with polar
function groups of -NH2, -CN, -Diol as well as polar adsorption media (such as BauloTMSi, ENVI-Florisil, and BauloTM-Alumina). This approach is typically used for normal phase
SPE, and has been used for selectively eluting drugs or other compounds from the organic
solvent.59

Figure 1.5

Procedures of solid phase extraction60

Reverse phase SPE is applied for purifying mid- or nonpolar analytes by using a midto nonpolar stationary phase to remove a polar sample matrix. The retention of analytes
onto the stationary phase of SPE primarily depends on hydrophobic interactions. Different
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kinds of materials, such as alkyl-bonded silicas (ENVI-18, LC-8), carbonaceous adsorption
media with hexagonal ring structure (ENVI-Carb), and polymeric adsorption media
(ENVI-Chrom P) were developed as reverse phase SPE materials. In contrast to normal
phase SPE, reverse phase SPE is more robust because it can retain most compounds with
a hydrophobic functional group. As a result, it has been a necessary step of sample
preparation in wide applications, such as proteomics,61 lipidomics,62 and drug monitoring
from complex biological matrices.63 For example, benzodiazepine is a class of
psychoactive drugs for treating anxiety, but it has a dangerous side effect of deep
unconsciousness from over-dosage. In order to accurately measure its concentrations in
patients’ blood, Inoue et al. used reverse SPE to clean up the sample and then transferred
the purified sample to GC-MS for quantitative analysis.63a
Ion exchange SPE is an extraction method, specifically designed for compounds,
which are charged in solution. The retention mechanism of the analyte onto the stationary
phase is primarily based on the electrostatic attraction of charged functional groups
between the target molecules and the sorbent surface. The ion exchange SPE column can
be divided as anion exchange SPE and cation exchange SPE according to the charge
condition of attracted species. Take the anion exchange SPE as an example. The sorbent is
modified with strongly basic function groups (like aliphatic quaternary amine group). As a
result, it forms positively-charged cations on the surface and thus attracts or exchanges
anionic molecules in the sample solution. The impurities and target molecules were then
sequentially eluted by adjusting the pH of the system. Filigenzi et al. reported to determine
the melamine in muscle tissue by LC/MS/MS with ion exchange SPE to clean up the
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analyte.64 This technique of ion exchange SPE was also applied in monitoring drugs in
biofluids.65
Due to the significant contributions of SPE in biological sample preparation, many
formats of SPE, such as column, cartridge, 96-well plates, and pipette tips, were designed
to meet the requirements of sample consumption from milliliters to microliters. Highthroughput automatic work stations were also established to accelerate sample treatments
for diagnosis.66 Furthermore, the adoption of the microfluidic chip technique enables SPE
to purify a sample of only several nanoliter volume. In 2005, Yang et al. developed a
polymer microchip and embedded an alkylacrylate based monolith polymer column in the
microchannel for the sample pretreatment and the separation before the ESI-MS analysis.67
In addition to above integrated SPE cartridges, magnetic beads were also used as the
stationary phase owing to their advances in flexibility and controllability. Generally,
magnetic beads were first modified with a specific functional group to attract target
molecules onto surfaces of beads. After being captured by a magnet, the magnetic beads
were washed by a washing solution to remove impurities. The analyte was finally eluted
from the beads by applying anther extraction solvent. Many types of magnetic beads were
developed for various applications, such as protein purification,68 nucleic acid testing,69
and antibody capture.70

(3) Chromatography
Chromatography is a method for separating analytes from a sample mixture, so that
they can be analyzed individually. The principle of chromatography is based on differential
partitioning between the stationary phase and the mobile phase, resulting in different
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retention times of analytes on the stationary phase. The phenomenon of chromatography
was first discovered by Mikhail Tsvet in the 1900s, when several pigments of a plant were
gradually separated from one color strip to several strips in one column.71 During the 1940s
to the 1950s, the partition mechanism was established by Martin and Synge, who shared
the Nobel Prize in chemistry for this achievement.72 Different types of chromatographic
methods, such as thin layer chromatography (TLC), GC, and LC, were quickly developed
based on this theoretical foundation and have become promising and powerful analytical
tools for biological sample analysis.
GC is typically used for separating volatile components of a mixture. Some less or
non-volatile compounds can also be separated through derivation or operation at elevated
temperature.73 To perform with GC, the sample is quickly vaporized in a high temperature
(200-300 oC) when it is injected into the instrument. A chemically inert gas (such as helium
or nitrogen) is used as a carrier gas to carry the sample through the separation column. The
stationary phase is either a layer of liquid or a solid adsorbent, experiments which are
termed as gas-liquid chromatography (GLC) or gas-solid chromatography (GSC),
respectively. The compounds with less affinity for the stationary phase are first eluted from
the column, and so separation is achieved.
Many achievements in identification and quantitation of small molecules (typically
MW < 1000 Da) in biofluids or tissues have been presented. For example, benzodiazepines
and other psychotropic drugs in human hair are easily analyzed by GC/MS.74 A
comprehensive review was also provided by Maurer on the systematic toxicological
analysis of drugs and their metabolites by GC–MS.75 Many detailed instrumental settings
can be found clearly for analysis of various drugs that are related to forensic toxicology or
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clinical diagnosis. Furthermore, GC-MS is also a frequently used as a tool to separate fatty
acids after extraction from biofluids or tissues. Typically, fatty acids need to be converted
to volatile non-polar derivatives before GC-MS.76 Since a large diversity of substituent
groups exists in the aliphatic chain in nature, preparation protocols are adjusted from case
to case.

77

For example, the degree of unsaturation and other functional groups (such as

cyclic, branched or hydroxyl moieties in the alkyl chain) obviously affects the fatty acid
derivatives, which can be identified by their relative retention times with a reasonable
degree of certainty.78
Compared to GC, LC broadens the range of the separation by implementing molecular
species with high molecular weights (MW>1000 Da). To perform LC, a sample mixture is
infused into a pressurized mobile phase. Each component is eluted at different flow rates
due to their interactions with the stationary phase in the separation column. Similar as SPE,
LC can be categorized into normal phase LC, reverse phase LC, and ion exchange LC
based on their different principles of separations. Take the separation of lipids as an
example. Lipids are a group of amphiphilic molecules, which have a polar head group and
at least one non-polar tail. Based on their amphiphilic structures, lipids can be separated in
two different ways: (1) Separation of lipids into different classes by the normal-phase LC
(NPLC) based on hydrophilic-hydrophilic interactions between head groups and the
stationary phase in the hydrophobic mobile phase.79 (2) Separation of lipids according to
the length and the unsaturation of acyl chains reverse-phase LC (RPLC) based on
hydrophobic interactions between hydrophobic acyl chains and the hydrophobic stationary
phase in the hydrophilic mobile phase.80
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In addition to separation methods above, hydrophilic interaction liquid
chromatography (HILIC) is an alternative method to NPLC, by using hydrophilic
stationary phases with hydrophilic mobile phases.81 Lipid separation under HILIC is based
on liquid-liquid partition mechanism where lipids elute in the order of non-polar to polar
lipids. The analysis time is generally in the range of 15-60 minutes. Compared to NPLC,
HILIC is more reproducible and more compatible with MS analysis.82
Moreover, the fact that lipids can be separated based on two independent structural
properties enables two dimensional LC (2D-LC) to overcome lipidomic challenges with
increasing complexity of the sample.83 2D-LC can be achieved in either an off-line mode
or on-line mode. For the off-line mode, each dimension can be fully optimized, but the
process is very time-consuming and labor-intensive, which comprises fraction collection,
solvent evaporation, and resuspension of the analyte with solvents for the second
dimension separation. In comparison, the on-line 2D-LC can be implemented
automatically for higher throughput, but the performance in the second dimension is
generally influenced by the first dimension. In many cases, NPLC or HILIC is performed
in the first dimension to fractionate lipids according to classes, followed by RPLC in the
second dimension for further separation of each fraction.84

1.1.2

Mass spectrometry for molecular analysis

Among analytical methods, mass spectrometry has stood in an outstanding position
owing to its exceptional characteristics: abundant structural information, high accuracy,
incomparable sensitivity, high speed, and a large variety of applications. Typically, the
analyte is first ionized by an ion source and then transferred into a mass analyzer for
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separation and measurement of ions with different m/z values. The fragmentation of massselected ions can also be accomplished by introducing inert gas into the mass analyzer for
further interpretation of the molecular structure. At the same time, target fragment ions are
counted and the signal is integrated into an electrical signal by the detector. After data
processing, a mass spectrum is finally plotted listing all the m/z values of detected ions in
the x-axis and their corresponding intensities in the y-axis. After undergoing many
improvements, MS has been a powerful tool for biochemical problems, such as diagnosis
of disease,85 drug monitoring,86 food safety,87 and so forth.
1.1.2.1 Ion source for MS analysis
Since only charged particles can be manipulated and analyzed by the mass
spectrometer, the analyte needs to be first ionized by an ion source before the MS analysis.
A variety of ion sources has been developed depending on the physical and chemical
properties of analytes as well as their matrices.
1.1.2.1.1 Traditional ionization methods
In 1918, electron ionization (EI) source was developed as the first ion source by
Dempster and was improved by Nier and Bleakeny.88 In this method, electrons are emitted
from a heated filament and collide with the gaseous molecules in the vacuum. During the
collision process, molecular ions and extensive fragments which can serve as fingerprints
of molecular structure are generated by transferring energy from electrons to neutral
molecules through the electronic excitation. The reproducible mass spectra for structural
elucidation and the inherent sensitivity in producing ions of EI have made the EI a popular
ionization method after GC separation.89
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Table 1.2 Proton affinities of structural group of lipid substances and common reagent
gases for lipid analysis by CI90
Structural Group in

PA (L)

Reagent Gas

Lipid Substance

(kcal/mol)

(B)

Isolated olefin

163-197

CH4

CH5+

132

Conjugated diene

193-205

H2O

H3O+

167

Alcohol

185-195

i-C4H10

C4H9+

196

177-199

NH3

NH4+

204

Carbonyl
(aldehyde or ketone)
Ester

190-202

Amines

214-249

BH+

PA(B)
(kcal/mol)

In 1966, another gas-phase ionization method, chemical ionization (CI), was reported
based on the charge exchange reaction between target molecules and primary ions in the
source.91 CI has been widely applied in analysis of lipid samples when it was newly
developed.92 In any CI experiment, reagent ions (BH+) are produced in an EI-typed ion
source operated at high pressure, and the reaction occurs efficiently because the proton
affinities (PA) of lipid molecules are greater than the PA of BH+. Table 1.2 briefly
summarizes proton affinities belonging to different functional groups of lipid substances
and common reagent gases for lipid analysis by CI.90 The rate of reaction is dependent on
the affinity difference and concentrations of BH+ and the lipid.
In addition, electron capture ionization (ECI) method was developed with very high
ionization efficiency of analytes in the negative ion mode. In this method, hot electrons are
cooled down to lower energy so that thermalized electrons are captured by target molecules
and transfer their energy to form excited molecular anions. The fragmentation may also
happen to stabilize the excited molecular anions (Figure 1.6). Lipids and drugs have been
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successfully ionized in the negative mode using this method.94 In order to simplify the
sampling, Gurkeerat et al. makes the ECI available in the atmospheric pressure condition
by displacement of electrons from the nitrogen sheath gas. Thus, the analyte can capture
the electrons in the gas phase in a manner similar to the conventional CI device.95 This
method has been used in targeted lipidomics.96

Figure 1.6 Schematics of the process during ECI of the target molecule M. Hot electrons
that are generated from the EI source are cooled down by successive collisions with neutral
gas molecules. The thermalized electrons are captured by target molecules and transfer
their energies to form excited molecular anions. The fragmentation may also happen to
stabilize the excited molecular anions.

As for the atmospheric pressure ionization, ions are generated in the atmospheric
pressure and are transferred to the high vacuum of a mass spectrometer with a differential
pumping system. Since the sample preparation is always taken under an atmospheric
pressure or even under a high pressure, for example the operating pressure of UPLC is up
to 18000 psi, the atmospheric pressure ionization method is more suitable to be an interface
of MS and thus has been widely applied in the drug analysis and lipid profiling.
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Figure 1.7 Schematics of the process during APCI. A LC elute is directly introduced to
a pneumatic nebulizer and transferred to a heated quartz tube with high-speed nebulizer
gas for desolvation. The analyte is then carried through a corona discharge electrode for
ionization sharing the same principle as CI.

In addition to atmospheric pressure ECI, atmospheric pressure chemical ionization
(APCI) was also developed as a popular atmospheric pressure ionization (API) method
sharing the same principle as CI.97 In APCI as shown in Figure 1.7, the analyte in solution
or a LC elute is directly introduced to a pneumatic nebulizer and transferred to a heated
quartz tube with high-speed nebulizer gas for desolvation. Then the analyte is carried
through a corona discharge electrode for ionization through molecular-ion reactions in the
gas phase. It is mainly used to ionize polar and relative non-polar compounds with medium
molecular weight up to 1500 Da and typically generates mono-charged ions. Some neutral
molecules, which are difficult to be ionized by other ion sources, such as carotenoid and
triacylglycerol (TAG), can be ionized very well with gentle fragmentation by APCI. In
1995, Byrdwell and Emken first demonstrated the separation of a TAG mixture by RPHPLC followed with the detection by the APCI-MS. The mass spectra of the TAG

24
standards display simple patterns of protonated molecular ions and little fragment ions as
primary peaks.98 In addition, Yee-Chung Ma et al. also characterized 29 steroids by the
APCI-MS and compared the results with those collected by electrospray ionization (ESI)
MS. APCI was less useful for analyzing steroid than the ESI, but the fragments produced
by the APCI give more hints for structural elucidation.99
In 1989, another important API method, ESI was developed by John Bennett Fenn, and
a charge accumulation was formed on the liquid surface in the capillary outlet and finally
led to a spray of highly charged droplets when a potential difference of 3-6 kV was applied
between the capillary and the counter-electrode.100 The generation of free ions in the ESI
is a complicated chemical process, so the mechanism has not been completely clear until
now. Two hypothesis have been widely accepted including ion evaporation model (IEM)
and charged residue model (CRM). IEM is based on the assumption that the solvated ions
can be ejected from the charged droplet as dry ions when the surface electric field is higher
than 1 V/nm with the decrease of the droplet size.101 This assumption has been verified to
be applicable in explaining the generation of relative small ions from ESI.102 At the same
time, CRM gives another possible explanation that a series of solvent evaporation and
Coulomb explosions split large droplets into many fine droplets containing only one solute
molecule in each droplet, and finally the formation of dry ions with the evaporation of the
rest of the solvent.103 This mechanism is more suitable for multiple-charged ions produced
from large molecules with molecular weight over 3000 Da.104
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Figure 1.8

Schematic of processes occurring during ESI105

ESI offers an efficient solution to ionize protein and other non-volatile molecules in
the solution phase. In addition, multiple charged ions can be obtained from large molecules,
allowing their molecular weights to be measured within a mass range up to 2000 Da. ESI
as an atmospheric pressure ion source also enables on-line LC separation and MS analysis.
Because of these features, ESI has been widely used in analysis of proteins and other large
biological molecules.106 At the same time, its application was extended not only to other
polymers, but also to analysis of drugs, lipids, and other small polar molecules.107 Both
positive and negative ions can be easily generated depending on the molecular structure of
the analyte. For example, phosphatidylcholine (PC) tends to retain a proton in the amino
group to form a positive ion, while free fatty acids (FA) and phosphatidylserine (PS) tend
to lose a proton from the carboxyl group to form a negative ion. In addition, the ESI is
sensitive to the concentration of analyte. This feature makes ESI-MS a reliable ion source

26
for quantitative analysis of drugs and lipids with internal standards to correct for the many
variables in ionization and mass analysis.107d, 108
1.1.2.1.2 Ambient mass spectrometry
As described above, the MS analysis always requires multiple sample pretreatments
to reduce the matrix effect, which is time-consuming and labor-intensive. To simplify the
sample treatment, the concept of “ambient mass spectrometry” (AMS) was first proposed
by Cooks and co-workers in 2004.109 Samples in their native states are directly ionized and
transferred to the gas phase for MS analysis with little or no sample preparation. This
concept was first demonstrated by desorption electrospray ionization (DESI), which shares
a similar ionization principle with ESI and has been one of the major subsets of the AMS.
Soon after DESI, a series of ambient ionization methods were developed based on different
mechanisms.
(1) Spray-based AMS
In DESI, the electrospray mist is continuously directed towards the sample surface to
form a liquid film and subsequent collisions splash secondary micro-droplets containing
extracted/dissolved analytes (Figure 1.9). During the droplet transference to the MS inlet,
dry ions are generated from the droplets in the same mechanism as the ESI. Typically, the
target molecule is identified by the m/z value in MS and its corresponding fingerprint
fragments produced by the tandem mass spectrometry (MS/MS).
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(A)

(B)

Figure 1.9 (A) Schematic of DESI-MS. Charged droplets impact on the surface of intact
sample and subsequent splash droplets with extracted/dissolved analytes for MS
analysis.109 (B) DESI-MS imaging of m/z 788.3 and m/z 885.3 on the surgical brain sample
with meningioma. The result is compared with optical image of H&E-stained serial section
comprising meningioma cells delineated with red lines.117(a)

Compared to the traditional ESI, DESI directly samples the analyte from an intact
sample surface without labor-intensive sample preparation. This advantage significantly
accelerates the throughput of the MS analysis and enables the development of a form of
ambient imaging mass spectrometry (IMS) that has been an important tool for
understanding spatial distributions of drugs or lipids in biological specimens.110,111 For
example, Vilmos Kertesz et al. investigated drug distributions of propranolol in different
mice tissue sections by the DESI-imaging.112 Concentration distributions of lipids have
also been profiled in different tissue types, comprising liver astrocytoma,113 arterial
plaques,114 adrenal glands,115 canine bladder carcinoma,116 and prostate cancer tissues in
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the positive or the negative ion mode.111 Interestingly, the lipid composition in the white
matter was found to be different from that in the gray matter, when DESI was applied to
analyze the lipids in the spinal cord and the brain.110 For example, phosphatidylserine (PS)
36:1 (m/z 788.5), phosphatidylethanolamine (PE) 40:4 (m/z 821.7), phosphatidylglycerol
(PG) 40:6 (m/z 821.7),

and phosphatidylinositol (PI) 38:4 (m/z 885.6) showed higher

abundances in the outer white matter than in the gray matter. At the same time, the gray
matter contains more FA 18:1 (m/z 281.3) and FA 20:4 (m/z 327.4). Furthermore, followup studies have determined boundaries between healthy and disease tissues (traumatic
injury tissue and brain tumors) in molecular levels by comparing their lipid distributions.117
For instance, the tumor metabolite 2-hydroxyglutarate (2-HG) has been demonstrated as a
target molecule to immediately provide a diagnostic and prognostic information for
isocitrate dehydrogenase 1-mutant tumors with tumor margins in both high specificity and
sensitivity.118 The integration of DESI image and 3D MRI also enhanced clinical decision
with both molecular and radiologic information. This methodology has been validated in
the operation room during the brain surgery.
In addition to the DESI, many other spray-based AMS methods have been developed
and used in monitoring drugs or for lipid profiling as summarized in Figure 1.10. Some of
these methods continue the desorption mechanism in the sampling process, like easy
ambient sonic-spray ionization (EASI).119 While another subset uses solvents to directly
extract analytes from biofluids or solid tissues, including paper spray (PS),120 touch
spray,121 leaf spray,122 needle biopsy and spray ionization,123 extraction spray,124 slug-flow
micro-extraction nano-ESI,58 probe electrospray ionization (PESI),125 liquid micro
junction-surface sampling probe (LMJ-SSP),126 and nano-DESI.127
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Figure 1.10

Summary of some spray-based AMS for drug monitoring and lipid
profiling

In PS-MS, the sample collection, storage, purification, and ionization occur in an
integrated fashion on a small triangular paper substrate. When the solvent and the high
voltage are applied to the paper substrate, analytes are directly ionized and sprayed from
the tip of the paper. Take drug monitoring in DBS as an example, the workflow of the PSMS comprises only 3-4 steps, including collection of the blood sample, making the blood
spot dried, cutting the paper, and applying high voltage and solvent to spray the analytes.120
Good quantitative performance has been demonstrated for five therapeutic drugs with
addition of their corresponding internal standards.128 The solid powder has also been
directly ionized by the paper cone spray ionization (PCSI).129 In addition, the same concept
is applied to direct analysis of plant tissues by leaf spray122 and animal tissues by PESI,125
touch spray,121 and needle biopsy and spray ionization.123 For leaf spray, fatty acids, amino
acids, and brassicins can be directly detected when the high voltage and the extraction
solvent were applied on the surface of the leaf; as for the animal tissue analysis, the sample
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is collected by a probe and ionized by applying solvent and high voltage to the probe or
the tissue. It was found that the formulation of the solvent plays an important role in both
extraction and ionization of analytes.130 In addition, the ionization efficiency was also
improved by integrating the nano-ESI tip with an extraction section because nano-ESI has
a better ionization efficiency by generating smaller charged droplets. For example, Yue et
al. developed extraction spray, where the DBS paper was inserted into a nano-ESI capillary
that is preloaded with the extraction solvent.131 Therefore, the analyte is directly extracted
from the DBS into the solvent for the MS analysis. LOD of 0.1 ng mL−1 of atrazine in the
river water can be achieved. In addition, the slug-flow micro-extraction nano-ESI enables
direct extraction and ionization of biofluids in the nano-ESI. LOD of 0.05 ng mL-1 has been
obtained for verapamil in the whole blood.132

(2) Plasma-based AMS
In 2005, direct analysis in real time (DART) was developed by Cody and coworkers
based on the plasma mechanism.133 As shown in Figure 1.11, a stream of ionized molecules,
excited state neutral molecules, electrons or radicals are generated by introducing a flowing
gas (such as helium or nitrogen) through an electrical discharge section by applying a high
voltage (1-5 kV) between the needle electrode and the ground electrode. A bias voltage is
also added at the perforated disk electrodes to allow only the excited state neutral molecules
entering the next chamber where there is an optional secondary heating. Then, the excited
state neutral molecules directly impact and vaporize the analytes from the sample surface
to desorb and ionize the analyte with the gas flow for MS analysis. This method does not
need any solvent to extract the analyte. In addition, singly charged ion species are mainly
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produced and displayed in the MS spectrum, so the structural elucidation is simpler than in
spray-base AMS.

Figure 1.11 Schematic of DART-MS.133 A stream of excited state neutral molecules is
generated by introducing a flowing gas through an electrical discharge section to which a
bias voltage is applied. The excited state neutral molecules then directly impact and interact
with the surface of the sample to desorb and ionized the analyte with gas flow for MS
analysis.

Since the ionization of large molecules is still challenging, applications of DART are
mainly focused on small molecules in mass ranges up to 1000 Da. The LOD has achieved
to 2 pg (7 fmol) of ethyl palmitate deposited on a glass rod with a signal-to-noise (S/N)
ratio of 70. The whole procedure only takes 30 s. In addition to structural identification,
good performance in quantitation was demonstrated by analysis of more than ten drugs in
the plasma.134 The linear ranges of these drugs were between 0.5-2000 ng/mL, which were
similar as the results under the ESI. The applications of DART also includes chemical
warfare agents,135 biotoxins,136 explosives,137 and food safety.138
At the same time, some other plasma-based AMS methods were applied in drug
analysis or lipid profiling, including plasma-assisted desorption/ionization (PADI),139
dielectric barrier discharge ionization (DBDI),140 flowing atmospheric-pressure afterglow
(FAPA),141 microplasma discharge ionization source,142 and low temperature plasma
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(LTP).143 Take the LTP as an example. The plasma is produced by the dielectric-barrier
discharge in the helium when a high-frequency alternating current (AC) voltage is applied
between a specially designed electrode configuration. The analyte can be directly desorbed
and ionized from the sample surface when the sample was exposed under the plasms. J.
Isabella Zhang et al. has successfully used LTP to detect the microbial fatty acid ethyl ester
(FAEE) mixtures from complex bacterial samples.144 It is noted that this work first applied
an AMS method to directly determine C=C double positions of unsaturated lipids that
significantly decreased the analysis time than conventional methods.145

Figure 1.12 Schematic of LTP-MS and the LTP mass spectrum of cis-9-octadecenoic
(18:1) acid in the positive ion mode144

On top of spray-based and plasma-based AMS methods, the sample can also be
directly ionized by thermal/chemical desorption ionization methods like desorption
atmospheric pressure photoionization (DAPPI)146 or by laser-based ionization methods,
which comprise laser ablation electrospray ionization (LAESI),147 and electrosprayassisted laser desorption ionization (ELDI).148 Drugs or lipids can be directly ionized for

33
structural determination and quantitation by MS. However, it is still a big challenge for
AMS to directly distinguish isomeric molecules, like determination of C=C double bond
positions and regioisomeric structure of lipids.

1.1.2.2 Tandem mass spectrometry (MS/MS)
Tandem mass spectrometry is a method involving multiple stages of ion selections
with fragmentations or chemical reactions occurring in between stages.149 Different from
the full scan (MS1) that directly analyzes ions according to their mass-to-charge ratios, the
most common type of MS/MS experiment first selects and isolates a precursor ion in a
mass analyzer for undertaking fragmentation or reaction between the two MS analysis
stages, and finally generates MS2 spectra presenting product ions in the next mass analysis
stage.
Since many fingerprint fragments of target molecules can be produced as
unambiguous evidence and significantly improved the S/N in the MS/MS spectrum,
tandem mass spectrometry has been a traditional method to elucidate the molecular
structures and determine quantities of lipids and small drugs. More structural information
can also been obtained by multiple stage mass spectrometry (MSn), which has been
achieved by using successive mass analyzers in space, or by conducting steps of MS/MS
in time, viz. ion-selection, ion-activation, and ion-dissociation sequentially in an ion storage
device. Table 1.3 gives a brief summary associating typical dissociation methods for
analysis of lipids and small drugs by tandem mass spectrometry.
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Table 1.3

Tandem mass spectrometry methods for analysis of lipids and drugs.

Tandem MS
Collision Induced
Dissociation (CID) 150
Electron Transfer
Dissociation (ETD)151
Electron Induced
Dissociation (EID) 152

Reaction
[M - nH]n- + N → fragments
[M + nH]n+ + N•- → [M + H• + (n-1)H](n-1)+ + N →
fragments
[M + nH]n+ + e- → [M + H• + (n-1)H](n-1)+ → fragments

*Precursor ions are shown in bold

In addition, four scan modes are generally available for tandem mass spectrometry in
different uses (Figure 1.13), including product-ion scan, precursor-ion scan, neutral-loss
scan, and selected reaction monitoring (SRM).

Figure 1.13

Tandem mass spectrometry scan modes153
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1.1.2.2.1 Product-Ion Scan
Product-ion scan includes selection of a precursor ion with a specific mass-to-charge
ratio and determination of all the corresponding product ions after the fragmentation.
Product-ion mode is typically used for interpreting structural information of particular
analytes with known molecular weights.

Figure 1.14 Product-ion spectrum of PS 36:2 (parent ion [M-H]-: m/z 786.8) in the
negative ion mode154

Take the structural characterization of PS 36:2 as an example. The spectrum in Figure
1.14 shows six fragment ions that were formed by dissociation of the PS 36:2 (precursor
ion: m/z 786.8) by the CID in the negative-ion mode. According to the mass spectrum,
peaks of the PO3- (m/z 79.2) and the [glycerophosphate-H2O-H]- (m/z 152.7) suggested that
this molecule was a phospholipid. This assumption was further confirmed by the neutral

36
loss of 87 Da (m/z 699.6) indicating that the head group of this phospholipid was PS or
LPS. Along with the PS, six other type-specific precursor ions or neutral loss (NL) for
identification of phospholipids were summarized in Table 1.4 in both the positive and the
negative ESI-MS, including PI or lyso-PI (LPI), PS or lyso-PS (LPS), PE or lyso-PE (LPE),
PC or lyso-PC (LPC), and sphingomyelin (SM).155 Additionally, the information of fatty
acid chains was determined by peaks of the [LPA 18:1-H2O-H]- (m/z 417.2), the [LPA
18:1-H]- (m/z 435.2), and the FA 18:1 (m/z 281.3), which suggested that PS 36:2 was
composed of acyl chains with 18 carbons and one C=C bond in each acyl chain, but the
C=C bond position cannot be directly obtained from the MS/MS spectrum.154
Table 1.4 Summary of type-specific precursor ions or neutral losses for identification of
phospholipids in the positive and the negative ion ESI-MS.155
Lipid class

Polarity

All [M-H]- of
phospholipids

Fragment
structure*

Fragment type

Scan mode

(-)

GlycerolphosphateH2O

Precursor of
m/z 153

PI / LPI

(-)

Head group -H2O

Precursor of
m/z 241

PS/LPS

(-)

Head group
-H3PO4

NL of 87 Da

PE/LPE

(-)

Dilyso -H2O

Sphingomyelin

(-)

Head group

PC/LPC
and
Sphingomyelin

(+)

Head group

Precursor of
m/z 184

PE/LPE

(+)

Head group

NL of 141 Da

PS/LPS

(+)

Head group

NL of 185 Da

Precursor of
m/z 196
Precursor of
m/z 168

*All the structures are chemically reasonable but in many cases not confirmed.
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Figure 1.15 ECD spectrum of LPC 18:1 (9Z).153 The head group of LPC is determined
based on the peak at m/z 184.072, the regioisomeric position of acyl chain is determined as
sn-1 based on the peak at m/z 226.080 in solid red line. Dashed red lines are used to validate
the sn-2 acyl group. The significant V shape intensity profiles with a pair of red dashed
lines indicates the double bond position between C9 and C10.

On top of previous structural information about lipids, the development of chargeremote fragmentation gives a serious of lipid fragments from which the structure of lipid
can be comprehensively determined.156 In this method, molecular ions with straight or
unsubstituted alkyl chains undergo fragmentation by losses of CnH2n+2 or CnH2n+1, resulting
in an array of peaks separated by 14 Da. This method has been applied in structural
identification of fatty acids, phospholipids, triacylglycerols, glycolipids, and steroids.157
Campbell et al. determined the regioisomeric positions and C=C bond positions of acyl
chains using EID (Figure 1.15).153 In this work, both lipid ions and electron beams were
simultaneously trapped in a quadrupole for reaction and then were ejected from the reaction
region for Time-of-Flight (TOF) analysis. Distinct fragments were displayed in the MS/MS
spectrum that clearly indicated the regioisomeric position of each acyl chain. Additionally,
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the EID also yielded many ions with spacing of 14 Da, which were attributed to the
fragmentation of acyl chain substituents of lipids. The C=C bond positions were
determined based on the peaks with less intensity for less cleavage in the C=C bond
position.
1.1.2.2.2 Precursor-Ion Scan
In the precursor-ion mode, all the ion species are separated in the first analyzer and
then are sequentially transmitted to the collision cell for fragmentation. The second
analyzer only transmits fragments with a specific mass-to-charge ratio formed in the
collision cell. Instead of showing all the fragment ions, the mass spectrum in the precursorion scan displays all the precursor ions that are dissociated to the target fragment with the
ion intensity in the second mass analyzer.

Figure 1.16 Identificatio of PCs and SMs by precursor-ion scanning of m/z 184 in an
unprocessed total lipid extract of CHO cells in the positive ESI-MS/MS.155

The precursor-ion scan is an extremely useful tool for shotgun lipidomics, especially
for identification of lipids from complex biological matrix.155 The SMs and PCs in the
biological specimen can be automatically detected by searching all the precursor ions that
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can be dissociated to m/z 184 fragments in the precursor-ion scan mode. The signal-tonoise ratio of the mass spectrum is also improved with less interferences of peaks derived
from other lipid types.
Furthermore, the quantitation of phospholipids has also been achieved by adding
internal standards in the precursor-ion scan mode.155 For example, in order to determine
concentrations of PCs in the cell extract, PC 28:0, PC 40:0, and PC 44:0 were added in the
extract as internals standards to bracket the profile of the naturally occurring PCs. A
calibration curve was established based on their peak intensities and compensations of loss
in sensitivity with the increase of molecular weights. The true molar abundances of PCs
was finally calculated based the calibration function.
1.1.2.2.3 Neutral-Loss Scan
Neutral-loss scan includes selection of a neutral fragment and detections of both the
precursor ions and the fragments that produce a constant mass offset as the neutral fragment.
In this mode, all the ion species are sequentially separated in the analyzer Q1 and
transmitted to the collision cell q2 for fragmentation. At the same time, analyzer Q3 scans
the fragments resulting from the neutral loss. Similar to the precursor-ion scan mode,
neutral-loss scan requires more than one mass analyzers to simultaneously monitor both
precursor ions and product ions. This method has been commonly used in identification
and quantitation of PS/LPS and PE/LPE species in shotgun lipidomics (Figure 1.17). In
addition, the precursor-ion scan and the neutral-loss scan are also widely used in the
identification of drug metabolites in the early phase of drug discovery because the neutralloss scan requires little structural information of target metabolites.158 For example, Jose
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Castro-Perez et al. developed a screening assay by monitoring conjugation of glutathione
and metabolites for the early diagnosis.159 In this assay, glutathione was used as a trapping
reagent to conjugate with the active phase I metabolites. Therefore, all the conjugates in
the complex matrix can be directly identified with a signature loss of pyroglutamic acid
with 129 Da in the neutral-loss scan mode.

(A)

(B)

Figure 1.17 Identification of PS and LPS by neutral-loss scanning of 87 Da in an
unprocessed total lipid extract of CHO cells by the negative ion ESI-MS/MS.155 (A) Mass
spectrum of lipids in the negative full scan. (B) Mass spectrum of possible PSs and LPSs
with neutral loss of 87 Da.
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1.1.2.2.4 Selected Reaction monitoring (SRM)
Instead of scanning ions, the selected reaction monitoring (SRM) only monitors a
product ion resulting from a fragmentation reaction of a selected precursor ion. The
absence of scanning helps the analyzer to focus on the precursor and production ions with
less interference from the biological matrices, and thus yield better LOQ and great time
saving.160 Therefore, this method has been a standard method in quantitation of drugs,
peptides, and proteins in a high sensitivity and selectivity.161

(A)

(B)

Figure 1.18 Quantitation of amitriptyline from the dried bovine blood by paper spray
mass spectrometry. The paper was pretreated with the isotopic-labeled [2H6] amitriptyline
as the internal standard.128 (A) Calibration curve of amitriptyline blood concentration
versus intensity ratio of the analyte and the internal standard. (B) Accuracy and
reproducibility of analyzing amitriptyline samples with six duplicates.

In order to determine the drug concentration in blood, a linear calibration curve is first
established with different concentrations of standard solutions versus the intensity ratio
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between the analyte and its isotope-labeled internal standard. Therefore, the concentration
of the sample can be calculated based on the intensity ratio and the calibration curve.
Nicholas et al. used this method to directly quantify 15 therapeutic drugs from the DBS by
the PS-MS, including sunitinib, citalopram, verapamil, and so forth (Figure 1.18).128 The
linear dynamic range covered three orders of magnitude (1-1000 ng/mL) with relative
standard deviations (RSDs) as small as 10% in each point. This performance has been
sufficient to monitor these drugs in their therapeutic windows.
In summary, tandem mass spectrometry is a useful tool in identification and
quantification of analytes by multiple stages of ion selection, dissociation, and detection.
Many tandem mass spectrometry methods have been developed for elucidation of
molecular structure, identification of a species type from complex matrices, or quantitation
of target analytes. In addition, the mass analyzer should be carefully selected to be
compatible for the analytical method.

1.1.2.3 MS analyzer
(1) Benchtop MS analyzer
The development of the mass analyzer has undergone milestones since the first mass
spectrometer was developed by J. J. Thomson in 1912.162 In Thomson’s work, he measured
m/z values of molecules by deflecting the beams in the electric and the magnetic fields.
The first mass spectrum records positions of several small gas molecules (including O2, N2,
CO2, COCl2, and CO) on a photographic plate, where the ion beam is direct to. Modern
techniques of the mass spectrometer were then quickly developed based on the same
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theoretical foundation. Techniques of direction focusing and velocity focusing were
developed by A. J. Dempster in 1918 and F. W. Aston in 1919, respectively.88a, 163 In 1957,
these two techniques were combined as double focusing and applied in the commercialized
mass spectrometer.
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Figure 1.19 Magnetic and electromagnetic mass analyzer.164 (A) Diagram of Thomson’s
positive ray apparatus. (B) Illustration of deflecting positive particles by an electric field.
(C) Photographic plate recording parabolas of neon by Thomson in 1912. (D) Mass
spectrograph of 22 isotopes achieved by Aston.

In addition to the deflection mechanism of ion separation, D. F. Eggers and A. E.
Cameron proposed a new concept of liner time-of-flight (LTOF) mass analyzer in 1946.165
The first LTOF-MS was built after two years and was finally commercialized by the
Bendix Corporation in 1958.166 At the same time, many other types of analyzers were
published. For example, ion cyclotron resonance (ICR) was first applied in a mass
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spectrometer in 1949 and was updated as the Fourier transformed ICR (FTICR) in 1974,
which broadened the linear dynamic range and brought outstanding mass resolution.168 In
1989, Hans Dehmelt and Wolfgang Paul were awarded a share of the Nobel Prize in
Physics for their development of the quadruple analyzer and ion trap techniques in 1953.169
The quadruple analyzer was also adopted in the development of the triple quadrupole mass
spectrometer.170 In 1999, the orbitrap was invested as a new type of mass analyzer using
an electrostatic quadrologarithmic field. The resolution is much higher than traditional ion
trap mass analyzers.171
The performance of the mass analyzer is generally evaluated by several parameters,
including mass accuracy, resolution, analysis speed, mass range limit, compatibility with
ionizer, and efficiency.172 Mass accuracy describes the accuracy of the m/z value measured
by the mass analyzer with the equation ΔM/M, where ΔM is the difference of m/z values
between measurement and theory, and M is the theoretical m/z value of the analyte. It is
expressed as parts per million (ppm). Typically, high resolution is necessary for high mass
accuracy of a mass analyzer. Mass resolution is a parameter indicating the limit of a mass
analyzer in distinguishing two different types of ions with very small m/z difference. It is
calculated as the ratio of average m/z value (Mavg) of the two adjacent peaks that are in
equal size and shape with a partial overlap to their m/z difference (ΔM). ΔM is defined as
the peak width at a specified height of the valley, which varies in mass analyzers. For
example, two peaks are regarded as resolved if the height of the valley is equal to 10% of
the peak intensity for the ICR-MS while 50% for the quadrupole, the Paul trap, and the
TOF. Speed reflects the maximum number of mass spectra that can be generated in a unit
time, which is influenced by the ion sampling. For example, the ion source, the mass
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analyzer and the detector work in parallel in the continuous ion sampling mode, so the
speed is determined by the time frame for obtaining a mass spectrum of ions in a specific
mass range. On the other hand, the experimental modules in the pulsed ion sampling work
stage-by-stage, so the calculation of the speed should consider the time consumption in
each stage. Mass range limit refers to the upper limit of mass-to-charge ratios over which
the mass analyzer accurately measures ions. Efficiency refers to the product of the
transmission of the mass analyzer and its duty cycle, where the transmission is defined as
the ratio of the number of ions reaching the detector to the number of ions entering the
mass analyzer, while the duty cycle is the proportion of target ions that are produced in the
ion source for the MS analysis. The efficiency is obviously higher if the mass range is
narrower.

Table 1.5

Characteristics of mass analyzer172-173

Equation
Resolution
Accuracy
(ppm)
Mass Limit
Speed (Hz)
Efficiency
(transmission×
duty cycle)
Ion Sampling
Tandem Mass
Spectrometry

Quadruple

Paul Trap

Orbitrap

FT-ICR

TOF

103-104

103-104

104-106

104-106

103-104

50-100

50-100

1-5

1-5

100-200

4 × 103
1-12 Hz

1.5 × 105
1-30 Hz

5 × 104
1-15 Hz

3 × 104
0.001-10 Hz

106
1-20 Hz

<1-95%

<1-95%

<1-95%

<1-95%

<1-95%

Continuous
MS/MS,
Precursors,
Neutral loss

Pulsed

Pulsed

Pulsed

Pulsed

MSn

MS/MS

MSn

MS/MS
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As the comparison in Table 1.5 shows, each type of mass analyzer has its own merits
and shortcomings, so the selection of the mass analyzer depends on the relative priority of
the requirements for a particular application over other merits. The combination of different
analyzers is also a common strategy to increase the versatility of MS and provide
complementary information on the analyte. The following will be more focused on the
selection of the mass analyzer for small drug monitoring and lipid profiling of biological
specimens.

a. Quadrupole analyzer (Q)
The quadrupole mass analyzer is a device composing of four parallel oscillating
electric rods. Ions with different mass-to-charge ratios are separated depending on their
differences in the stability of trajectory in the oscillating electric field (Figure 1.20). When
the accelerated ions enter into the quadrupole, they are drawn towards two electric rods
with the opposite charge to the ions. The running direction of ions are changing because
the sign of the potential on the rods are changing with time. As a result, only ions with
the selected m/z values can be focused in the center of the field and safely pass through the
quadrupole by carefully adjusting the oscillating electric field.

Figure 1.20

Quadrupole mass analyzer
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The quadrupole in the RF-only mode is also frequently used as an ion guide or a
collision cell before other mass analyzers. An ion guide is a focusing device to transport
ions from one position of the mass spectrometer to another, which can obviously improve
the sensitivity of the mass analyzer by reducing ion loss during the transportation. Other
multipoles, such as hexapoles and octapoles, have also been applied as ion guides for
simultaneous transmission of ions in the higher mass range. They are especially helpful to
mass analyzers that measure all the ions simultaneously, such as TOF. While quadrupole
is more suitable for the scanning mass analyzers because quadrupoles have better focusing
performance and the scanning mass analyzers do not require a very wide mass range.

Figure 1.21

Schematic diagram of a triple quadrupole mass spectrometer

In 1978, the first triple-quadrupole mass spectrometer was developed by arranging
two quadrupole mass-filters in tandem (Q1 and Q2) with an additional collision cell (q) in
between as “triple quads” (Figure 1.20). This design provides more tandem mass
spectrometry options by a number of different “tandem-in-space” scan modes that cannot
be achieved by “tandem-in-time” mass analyzers. As described in section 1.1.2.2, the
precursor-ion scan and the neutral-loss scan are generally performed in the triplequadrupole mass spectrometer to analyze lipids according to their type-specific precursor
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ions or neutral loss.174 In addition, excellent quantitation has also been achieved by SRM
with less interference from other ions in biological samples.175

b. Ion-trap (IT) analyzer
The ion-trap analyzer is a “tandem-in-time” mass analyzer that stores and activates
ions into fragments sequentially in the same device (Figure 1.22). Many types of ion-trap
mass analyzers have been developed based on different principles, including Q-trap,
orbitrap, and FTICR.

(A)

Figure 1.22
trap.176

(B)

Schematic of (A) the 3D-quadrupole ion trap and (B) the 2D-quadrupole ion

In the Q-trap, ions of different masses are trapped together by an oscillating quadrupole
electric field, and then are expelled according to their mass-to-charge ratios so as to reach
the detector for profiling the mass spectrum. The Q-trap has been widely used in structural
elucidation of drugs in complex biological matrices because it can perform tandem mass
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spectrometry for more than two stages. During MSn, only the selected fragment ions are
trapped and activated to form smaller fragments. As a result, more structural information
can be obtained by doing MSn with less isobaric or isomeric interferences. Franklin et al.
have characterized the drugs with nitrogen-containing saturated ring structures and
explained their fragmentation pathways based the MSn mass spectra.177
Instead of RF-field, the orbitrap mass analyzer traps ions by an electrostatic field in a
trapping cell

171

It is composed of a spindle-shaped central electrode and a barrel-shaped

external electrode with a small interval (Figure 1.23). To perform the ion trap, ions are
tangentially injected and oscillate in the interstice around the central electrode under the
influence of the electrostatic field between the two electrodes. The mass-to-charge ratio is
measured based on the oscillating frequency followed by the Fourier transformation of the
time domain signal transient. Compared to the quadrupole ion trap, the orbitrap mass
analyzer provides a much higher resolving power (resolution: 104-106) and higher mass
accuracy (1-5 ppm). This feature offers a chance in precise identification of the molecular
species in complex matrices that cannot be achieved by the Q-trap. Take the shotgun
lipidomics as an example. The mass-to-charge ratio of alkylacyl species of even carbon
numbers is approximated with those of the diacyl species of odd carbon numbers in the
negative mode, which may lead to peak overlaps between these two lipid species in the low
resolution. By using the orbitrap, these two species can be easily separated and
identified.178
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(A)

(B)

Figure 1.23

Schematic of (A) orbitrap and (B) FT-ICR177

In addition to the orbitrap, the high resolution can also be achieved by the FT-ICR,
which is another type of ion-trap mass analyzer. In the FT-ICR, the m/z values of ions are
determined according to their circulating frequency in a magnetic field, which is measured
by the resonance absorption of an external electromagnetic wave. The ultra-high mass
accuracy and resolution make the peak abundances more reliable in reflecting the sample
composition by decreasing the chemical interferences from molecules with similar massto-charge ratios. For example, Mycobacterium tuberculosis (Mtb) is a causative agent of
tuberculosis.180 It synthesizes and excretes many biologically active polyketide lipids that
interact with the host, so these lipids may possibly be served as biomarkers in the diagnosis
of tuberculosis. In order to find these lipids, Madhulika et al. used the FT-ICR MS to
simultaneously measure abundances of hundreds of lipid species that were directly
extracted from the Mtb cells.181 It was found that the sizes and abundances of two lipid
virulent factors, phthiocerol dimycocerosate and sulfolipid-1, were positively related to the
concentration of the methyl malonyl CoA (MMCoA). Furthermore, a small change of
MMCoA metabolism reduced the pathogen replication in the mice. Based on this
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observation, it was proposed that the increase of fatty acids in the Mtb leaded to the increase
of the virulence lipid synthesis by increasing the flux of MMCoA through lipid biosynthetic
pathways. In addition, a fatty acid analysis tool (FAAT) was also developed as a computer
algorithm for interpreting lipid structures based on the FT-ICR mass spectra.182 Multiple
spectra of complex lipid extracts of M. tuberculosis and M. abscessus can be interpreted
within tens of seconds by using the FAAT.

c. TOF analyzer
TOF is another type of mass analyzer in which mass-to-charge ratios of ions are
determined according to the time measurements in the flight tube. It is basically composed
of a source region and a flight tube. After transferred in the source region, ions are
accelerated to the flight tube under an acceleration electric field with potential (Vs). Since
all the ions share the same kinetic energy (Ek), their velocities v are related to their masses
as in equation (1.1).
𝐸𝑘 =

1
2

𝑚𝑣 2 = 𝑧𝑒𝑉𝑠 = 𝐸𝑒𝑙𝑒𝑐𝑡𝑟𝑖𝑐

(1.1)

As a result, when they are sent to the field-free flight tube, ions can be separated based
on their velocities. Theoretically, their mass-to-charge ratios can be calculated according
to the drift time (t) as equation (1.3).
t=

𝐿

(1.2)

𝑣

𝑡2 =

𝑚
𝑧

𝐿2

(2𝑒𝑉 )
𝑠

(1.3)
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Figure 1.24 Linear TOF mass analyzer with a single acceleration stage and schematic
flight paths for two ions, in which the orange ion is lighter than the green one.

When the first TOF analyzer was established, the most obvious drawback was its poor
mass resolution.165 Many efforts have been made to solve this problem. For example, since
the resolution of the TOF is proportional to the flight distance, one method is to lengthen
the flight tube. As a result, the size of the TOF mass analyzer can be very big. In 1973, an
alternative method of lengthening the ion path was developed with reflectrons. One or more
ion mirrors were set to deflect and send ions traveling in the flight tube back and forth.
However, the transmission efficiency was decreased due to the ion loss from the angular
dispersion or the ion scattering. In addition, the development of “delayed pulsed extraction”
significantly improved the resolution by reducing the kinetic energy spread among ions
with the same mass-to-charge ratio.183 In this method, an extraction pulse was applied after
a certain delay, so ions with lower velocities got more energy due to staying in the
acceleration region for longer time. Apart from resolution, the interface between the
continuous ion source (like ESI) and the TOF analyzer is also a big challenge because TOF
system works on a pulsed process. The development of orthogonal acceleration allows this
combination and makes the continuous ion source enjoy the incomparable merits of TOF
in high mass range and high speed.
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Compared with other mass analyzers, the most significant advantage of the TOF is its
broad mass range. The introduction of MALDI makes the TOF more powerful in analyzing
large molecules. For example, antibody-drug-conjugates (ADC) are targeting drugs which
are composed of monoclonal antibodies, small biologically active drugs and a specially
designed linker. The drug loading of each antibody is very sensitive and highly important
for clinical treatment and quality control in pharmaceutical production. However, the
measurement of drug loading is still a big challenge due to the ultra-high molecular weight
of the antibody and the complexity of the drug loading. Currently, the MALDI-TOF is the
only mass spectrometric tool for determining drug loading in the ADC based on its wide
mass range.184 At the same time, peptide drugs have been a hot area. During the past decade,
more than 60 peptide medicines has been approved by the FDA and about 600 peptide
drugs are currently under preclinical development or in clinical trials.185 In the development
of peptide drugs, the MALDI-TOF also makes obvious contributions in the mass
measurement and the peptide mapping. For instance, Sang-Heon Lee et al. has successfully
synthesized a new type of Glucagon-like peptide-1-(7−36) for the treatment of type 2
diabetes mellitus.186 During the synthesis, the reaction was monitored at different time
intervals by the MALDI-TOF-MS to achieve an optimal condition.
Apart from large molecules, the TOF analyzer was also applied in analyzing small
drugs and lipids, especially in profiling spatial distributions of analytes by using the
MALDI imaging. For example, the drug olanzapine (OLZ) and its two metabolites have
been reported to be directly profiled in the whole-rat.187 The result showed a good
correlation with both quantitative results by LC/MS and autoradiography. Furthermore, the
TOF analyzer was also used for lipid analysis coupled with ion mobility and MALDI. 188
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In this study, ions of lipids are first separated from isobaric ions of drugs, metabolites,
peptides, and proteins by the ion mobility, and then analyzed by the TOF-MS. This allows
a higher sensitivity for the lipid analysis. However, it is limited in imaging small molecules
because of matrix interference.

(2) Miniaturized mass spectrometer
Miniaturization of the mass spectrometer is an important trend in instrumentation,
especially for the on-site analysis.189 The ideal example has been shown in the Figure 1.25
where sample testing can be completed simply by dropping the biological sample on a
cartridge, putting into a mini-MS, and then the result can be directly displayed in the screen.
This type of device could be taken to anywhere needed: a factory for process monitoring,
an open country for environmental analysis, a police station, a site of the explosion, or even
a family home. This kind of device can also be customized according to some specific
requirements for compatible performance in the rapid analysis. In addition to the
contributions of AMS mentioned above to realize this aim, many efforts have been done in
the development of the Mini-MS.
(A)

(B)

Figure 1.25 (A) Workflow of chemical analysis using the bench-top MS. (B) Conceptual
design of the Mini-MS for automated analysis.189
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The miniaturization of the mass spectrometer has proceeded via three steps: (1) the
miniaturization of mass analyzers, (2) the development of integrated mini-MSs, and (3) the
development of self-sustained Mini-MS analytical systems.189 With the application of
microelectromechanical systems in the fabrication, different types of mass analyzers have
been minimized in size from micrometer to centimeter scale, including the ion trap,190
TOF,191 double-focusing magnetic analyzer,192 and quadrupole.193 A collaborative group
from Imperial College and Liverpool University in the UK developed the first fully micromachined quadrupoles in silicon with rods 0.5 mm in diameter and 20-30 mm in length.194
In addition, Pau et al. fabricated an array of cylindrical quadrupole ion traps with a radius
of 20 μm for each ion trap.190b

At the same time, theoretical modeling and numerical

simulations are also complemented to study and optimize the performance of analyzers.195
(A)

(B)

Figure 1.26 (A) Photograph of Mini-11.196 (B) A self-sustained analytical system and
simplified operational protocol achieved by Mini-12.197

After several recapitulations in the design of integrated Mini-MS, a series of portable
mass spectrometers were developed, such as Mini 10, Mini 11, QitTOF, TinyTOF and so
forth.190a, 196, 198 As shown in Figure 1.26 (A) The weight of Mini 11 has been reduced to 8
lb, which can be easily lifted. In the aspect of the analytical performance, resolutions of
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mass analyzers are unequally degraded under higher operating pressures with reducing the
size of diaphragm pump and turbomolecular drag pump.196 In addition to improving the
performance of pumps,199 the development of discontinuous atmospheric pressure interface
(DAPI) lowers the requirement of the Mini-MS in terms of pumping capacity, and thus
contributes to the development of self-sustained chemical analysis systems in combination
with ambient ionization methods. Recently, the Mini-12 as a benchtop miniature mass
spectrometer was developed with paper spray ionization method and tandem mass
spectrometry capabilities (Figure 1.26 (B)).197 Therapeutic drugs in the blood sample can
be directly ionized by the paper spray and analyzed by the rectilinear ion trap with a mass
range of up to m/z 900 with

peak width of Δ m/z 0.6 Th. Multistage tandem mass

spectrometry can also be completed up to MS5. A user interface allows users easily obtain
the analytical results without much mass spectrometry skill. Good quantitative
performance has been demonstrated in monitoring chemicals for the food safety and
therapeutics.

1.2

Conclusion

In summary, this section has introduced the current mass spectrometric methodologies
for analysis of drugs and lipids from biological specimens. Abundant structural information
and accurate quantitative results can be obtained by lab-scaled MS experiments with a
series of sample pretreatments, such as SPE, GC, LC, and so forth. However, the timeconsuming sample preparation limits the throughput of the analysis. Some inconveniences,
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including degradation during the transportation and expensive transportation cost also
hinder the application of the MS in the real sample analysis.
AMS provides an alternative strategy with the combination of the sampling process
and ionization process, so that the analyte is directly ionized without or with minimal
sample preparation. The total analysis time can be significantly reduced with adequate
sensitivity. Among these AMS methods, paper spray has been demonstrated as a simple
and robust ion source with good quantitative performance, which can be potentially used
in fast screening of antibiotics in foods for the food safety, as well as illegal drugs in
biofluids for the forensic or therapeutic use. In addition, it has been found that chemical
interferences from the paper can be reduced by oxidation of the paper substrate, so its
quantitative performance can be enhanced by this paper modification.
Meanwhile, in the application of lipid profiling, many AMS methods can effectively
extract and ionize lipids from tissues, but the structural information is very limited if the
interpretation only depends on the information from the conventional CID-based product
ion scan tandem mass spectrometry. Direct determination of the positions of C=C double
bond is still a big challenge for AMS although it has been solved by the reactive tandem
mass spectrometry in the conventional ion source. Currently, the combination of LTP and
ozone-induced dissociation enables the identification of C=C bond positions of microbial
fatty acid ethyl ester mixtures. However, there is no report about lipids with higher
molecular weights like phospholipids. Compared with microbial fatty acid ethyl ester
mixtures, the tissue samples also increase the complexity of the matrix, rendering more
difficulties in pinpointing C=C double bond positions of the target lipids. In order to fill
these gaps, isomeric structures of unsaturated lipids from tissue samples, to the best of the
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authors’ knowledge, were first directly determined with systematic structure profiles by
the AMS method. Such approach was implemented by extraction spray and on-line PB
reaction. Lipids were directly extracted by sticking a stainless steel wire into a chunk tissue
and then immersing into a nano-ESI capillary preloaded with the solvent for extraction,
reaction, and detection by ESI-MS. A UV light (λ=254 nm) was used to facilitate the PB
reaction to form reaction product ions (+58Da) added with an oxetane ring at the original
location of the C=C bond, which was subsequently cleaved by CID to produce
characteristic fragment ions. The unsaturation of lipids in a broad dynamic range of
concentrations could be identified with good reproducibility. What is more, since the
sample consumption of the present method could be as low as 10 μg/sample, isomeric ratios
of unsaturated lipids were also first mapped for the rat’s brain and kidney. Significant
differences in isomeric ratios of lysophosphatic acid (LPA) 18:1 and phosphatic acid (PA)
18:1-18:1 were observed in different regions of the rat’s brain, while isomeric ratios of
fatty aicd (FA) 18:1 was relatively stable in both the rat’s brain and kidney.
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QUANTITATIVE PAPER SPRAY MASS SPECTROMETRY
ANALYSIS OF DRUGS OF ABUSE

2.1

Introduction

Drug abuse is a serious problem worldwide with approximately 200 million users of
illicit drugs.1 Many addictive drugs have valuable therapeutic effects in the clinical use.
For example, buprenorphine, oxycodone, and heroin are useful analgesics, but abuse of
these drugs has a large impact on addicts' health as well as their social lives.2 Analysis of
drugs in biofluids, such as urine and blood, is applied for screening drug users as well as
for monitoring them whilst undergoing therapy.3 In the development of therapeutic drugs
for the treatment of the drug abuse, dosing guidelines are established on the basis of
pharmacokinetic (PK) and pharmacodynamic (PD) clinical studies; these studies are
dependent on the analysis of therapeutic drugs as well as drugs of abuse and their
metabolites in the blood.4 The use of drugs in the therapy, such as the pain relief drug
buprenorphine often used in the management of opioid dependence, is strictly controlled
to avoid addiction and other side effects.5
Currently, immunoassays are widely used for the rapid screening of drugs of abuse. 6
The confirmation of positive results is achieved by liquid chromatography mass
spectrometry (LC-MS) or gas chromatography mass spectrometry (GC-MS), which are the
most reliable methods for chemical identification and quantitation of drugs.7 To achieve
high accuracy and sensitivity in the LC-MS and GC-MS, samples of biofluids need to be
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carefully prepared. For the blood analysis, the sample preparation consists of
depositing the blood onto a disk to form a dried blood spot (DBS), punching out the DBS,
extracting the analytes, followed by the purification and concentration by the LC or GC.8
This type of multi-step procedure works well for the chemical analysis of large batches of
samples. Single-step methods based on the ambient ionization mass spectrometry have also
shown their good sensitivity for analyzing target analytes in complex mixture samples.9 In
the ambient ionization mass spectrometry, the analytes are directly ionized from a sample
in its native state and transferred into the gas phase for MS analysis with little or no sample
preparation. Starting with desorption electrospray ionization (DESI)10 and direct analysis
in real-time (DART),11 many ambient ionization methods have been reported, such as
atmospheric solids analysis probe (ASAP),12 surface sampling probe (SSP),13 extractive
electrospray ionization (EESI),14 laser-ablation electrospray ionization (LAESI),15 matrixassisted laser desorption electrospray ionization (MALDESI),16 and atmospheric-pressure
thermal desorption ionization (APTDI).17 The application of ambient ionization to the
analysis of DBS samples is of significant interest, since the DBS is becoming a standard
method for the storage and transportation of blood samples.18 A very small amount (10-20
μL) of blood is needed for one DBS, which allows less invasive methods for screening,
such as the finger prick, to be utilized when taking the sample. Collectively, these
techniques could potentially provide great advantages in the high-throughput screening for
drugs of abuse and for the development of therapies to treat the abuse. The drugs and their
metabolites can be quickly analyzed without extensive sample treatment. However, high
accuracy and reproducibility in quantitation needs to be assured to establish the validity of
these applications and this is the topic of this chapter.19
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Paper spray mass spectrometry (PS-MS) has recently been used as an ambient
ionization method in a range of problems including therapeutic drug monitoring,20 food
safety,21 neonatal screening,22 and tissue analysis.23 To perform the PS-MS, the sample is
deposited on a piece of chromatographic paper in a triangle shape to form a dried sample
spot. A small amount (10s of microliters) of spray solvent is applied onto the paper to
extract the analytes from the sample, which are subsequently ionized in the spray produced
when a high voltage is applied onto the paper. When internal standards (IS) are mixed into
the sample, highly precise quantitative results have been obtained for the PS-MS. Hence,
the PS-MS is suitable for high-throughput DBS analysis at extremely low-cost and organic
solvent consumption. In this chapter, we report the development of a rapid method of
screening and quantitative determination of drugs and their metabolites based on DBS
analysis using the PS-MS associated for the screening and therapy of drug abuse. The entire
analysis process for one sample takes less than one minute with acceptable limits of
quantitation (LOQs) in a linear range. Pretreatment of the paper substrate by oxidation has
been found to be effective in reducing interferences due to chemicals in the paper.

2.2

Materials and instrumentation

Cocaine, heroin, morphine, 6-acytalmorphine, benzoylecgonine, methamphetamine,
oxycodone, and buprenorphine were purchased from Sigma Chemical Co. (Sigma-Aldrich,
St. Louis, MO). Morphine-d3, benzyolecgonine-d3, cocaine-d3, 6-acetylmorphine-d3,
methamphetamine-d8, oxycodone-d6, and buprenorphine-d4 were obtained from the
Cambridge Isotope Laboratories, Inc. (Cambridge Isotope Laboratories, Inc., Tewksbury,
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MA). Different concentrations (0.1-1000 ng/mL) of the samples were prepared by gradual
dilution with the bovine blood (Innovative Research Inc., Novi, MI).

Figure 2.1

Schematic representation of paper spray mass spectrometry for drug abuse
monitoring

The instrumental setup and the general analysis procedure for paper spray have been
reported in previous papers.24

In this study, 15 μL of blood was collected and stored in

the form of a dried blood spot on a paper triangle (10 mm base width × 20 mm height). A
metal clip was used to hold the paper horizontal and conduct the high voltage for the paper
spray ionization. The distance between the tip of the paper and the inlet of the mass
spectrometer was about 5 mm. After being drenched with 25 μL of a 90% acetonitrile/ 10%
water solution (v/v), a voltage (3500 V) was applied for the spray ionization. The MS
spectra were recorded using an Exactive Orbitrap mass spectrometer (Exactive, Thermo
Scientific, CA). Quantitation of drugs in blood was carried out by tandem mass
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spectrometry (MS/MS) using a TSQ Quantum Access Max mass spectrometer (Thermo
Scientific, CA) in the multiple reaction monitoring (MRM) mode with an isolation widow
width of m/z 0.4. The LOQ was calculated as 10× the standard deviation of the background
noise divided by the slope of the calibration curve experimentally obtained. Bovine whole
blood with K2EDTA as anticoagulant was purchased from Innovative Research (Novi, MI).

2.3

Results and discussions

2.3.1 Direct identification of abused drugs by paper spray mass spectrometry
In many cases, the concentrations of a drug and its metabolites could be used for drug
abuse screening as well as in therapeutic drug monitoring, especially for those drug
compounds with short metabolic half-lives. For example, cocaine has a short half-life
(about 1 h) and its metabolite benzoylecgonine is typically used in analysis. As shown in
Figure 2.2 a and b, 100 ng/mL of cocaine [(M+H)+, m/z 304.0; product ion, m/z 182.0] and
its metabolite benzoylecgonine [(M+H)+, m/z 290.0; product ion, m/z 168.0] were
identified and confirmed using MS/MS. The high signal-to-noise (S/N) ratios in the
MS/MS spectra for the analyte peaks indicate the high sensitivity of the current PS-MS
method in quantitation of these abuse drugs at trace levels in blood. The parameters for
MRM analysis are listed in Table 2.1.
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Table 2.1

Tandem mass spectrometric parameters for paper spray.
Drug

Precursor ion
(m/z)

Morphine
[C17H19NO3+H]+

286.1

Morphine-d3

289.1

Benzyolecgonine
[C16H19NO4+H]+

290.0

Benzyolecgonine-d3

293.0

Cocaine
[C17H21NO4+H]+

304.0

Cocaine-d3

307.0

6-acetylmorphine
[C19H21NO4+H]+

328.3

6-acetylmorphine-d3

331.3

Methamphetamine
[C10H15N+H]+

150.1

Methamphetamine-d8

158.1

Oxycodone
[C18H21NO4+H]+

316.1

Oxycodone-d6

322.1

Buprenorphine
[C29H41NO4+H]+

468.2

Buprenorphine-d4

472.2

Product ion
(m/z)
201.0
-(C4H7NO)25
201.0
-(C4H4D3NO)
168.0
-(C7H6O2)26
171.0
-(C7H6O2)
182.0
-(C7H6O2)27
185.0
-(C7H6O2)
164.9
-(C6H13NO4)28
164.9
-(C6H10D3NO4)
91.1
-(C3H9N)29
93.1
-(C3H3D6N)
298.0
-(H2O)30
241.0
-(C3H7O2)
304.8
-(H2O)
247.0
-(C3H7O2)
396.1
-(C4H8O)31
400.1
-(C4H8O)

Collision
energy (V)

Tube
lens

25

102

25

102

18

146

18

146

20

78

20

78

26

117

26

117

24

69

24

69

20

80

26

80

20

80

26

80

36

64

36

64
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Figure 2.2 MS/MS spectra of (a) cocaine [(M+H)+, m/z 304.0; product ion, m/z 182.0]
and (b) its metabolite benzoylecgonine [(M+H)+, m/z 290.0; product ion, m/z 168.0] at 100
ng/mL in whole bovine blood. Linear dynamic ranges obtained using IS premixing for (c)
cocaine and (d) benzoylecgonine by paper spray.

2.3.2 Effect of solvent on the PS-MS
The spray solvent composition was optimized to achieve the best performance for the
drug compounds in the DBS. In PS-MS, the spray solvent plays a role in both analyte
extraction and electrospray from the tip of the paper substrate.24, 32 Seven pure organic
solvents including acetonitrile, methanol, ethanol, propanol, butanol, isopropanol, and
ethyl acetate, were tested. The most accurate S/IS ratios for benzoylecgonine (measured by
the intensities of product ion m/z 168 and m/z 171) were obtained using acetonitrile (Figure
2.3 A). We further optimized the solvent composition by adding water to acetonitrile and
monitoring the analyte-to-IS (A/IS) ratios. As shown in Figure 2.3 B, the highest signal
intensity occurred with 90% acetonitrile/10% water (v/v) solution and decreased rapidly
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with increase in the percentage of water. The A/IS ratio also became less reproducible and
less accurate when the percentage of water exceeded 50% (Figure 2.3 C). This presumably
is because the increase of water percentage resulted in dissolving more water-soluble
chemicals from the DBS that interfered with the ionization of the analytes during the spray.
This matrix effect would decrease the ionization efficiency by ion suppression during the
ionization process and then lead to a lower signal intensity.
(B)

S/IS

Relative Intensity of m/z 168.02

(A)

(C)
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Percentage of Acetonitrile in
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Solvent

Percentage of Acetonitrile in
Water (% v/v)

Figure 2.3 Optimization of experimental conditions for quantitative paper spray mass
spectrometry. (A) Effect of spray solvent on the ratio of analyte to internal standard (A/IS)
of benzyolecgonine [(M+H)+, m/z 290.0, product ion, m/z 168.0] and benzyolecgonine-d3
[(M+H)+, m/z 293.0, product ion, m/z 171.0]. Effect of acetonitrile percentage in water on
(B) the signal intensity and (C) the ratio of analyte to internal standard (A/IS) of
benzyolecgonine.
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2.3.3 Effect of sample amount on the PS-MS
The impact from the DBS size and the sample amount has also been characterized. The
signal intensity increased with the increase in blood sample amount while the variation in
A/IS ratio was relatively small (Figure 2.4). It was found that the lowest RSDs for the A/IS
ratio were obtained with 10 μL or 15 μL of blood sample. As a result of the optimization
procedure, 20 μL 90% acetonitrile/10% water (v/v) solution and DBS preparation with 15
μL blood sample were used for the analysis of drugs of abuse.

(A)

A/IS

Signal Intensity of m/z 168.02

(B)

Size of Blood Spot (μL)

Size of Blood Spot (μL)

Figure 2.4 Optimization of experimental conditions for quantitative paper spray mass
spectrometry. Effect of blood spot size on (e) the signal intensity and (f) the ratio of analyte
to internal standard (A/IS) of benzyolecgonine [(M+H)+, m/z 290.0, product ion, m/z 168.0].

2.3.4

Quantitative performance of PS-MS

Quantitation of cocaine and benzoylecgonine in the DBS was characterized with the
results shown in Figure 2.5. Drug solutions were sequentially diluted by the bovine whole
blood to make a set of samples at concentrations of 1, 10, 50, 100, 500 and 1000 ng/mL
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(or 800 ng/mL). The isotope-labeled internal standards (Table 2.1) were added at 100
ng/mL. LOQs of 0.5 ng/mL and 1 ng/mL were achieved for cocaine and benzoylecgonine.
Good linearity of the calibration curve was obtained for both cocaine (R2 = 0.9986) and
benzoylecgonine (R2 = 0.9918) over 3 orders of magnitude (Figure 2.5 C and D), which
was sufficient to cover the whole monitoring range of cocaine and benzoylecgonine for
abuse screening and therapeutic purposes. An RSD smaller than 12% was obtained across
the entire linear range for both cocaine and benzoylecgonine.

Figure 2.5 Determination of drugs of abuse in DBS using the 31 ET paper for paper spray.
MS/MS spectra of (a) cocaine [(M+H)+, m/z 304.0; product ion, m/z 182.0] and (b) its
metabolite benzoylecgonine [(M+H)+, m/z 290.0; product ion, m/z 168.0] at 100 ng/mL in
the whole bovine blood. Linear dynamic ranges obtained using IS premixing for (c) cocaine
and (d) benzoylecgonine.
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Quantitation of other abused and therapeutic drugs as well as their metabolites in
blood using the PS-MS was also characterized in a similar fashion, including oxycodone,
buprenorphine, methamphetamine, morphine, and 6-acetylmorphine. LOQs and the linear
ranges of the calibration curve obtained with both IS incorporation methods are reported
in Table 2.2.

Table 2.2

Comparison between LOQ of paper spray and regulatory cut-off level.a

Screening
Linear
LOQ
cut-off level range
(ng/mL)
(ng/mL)
(ng/mL)
Heroin
Morphine
5
20
5-800
6-acetylmorphine
5
20
5-800
Cocaine
0.5
50
0.5-1000
Benzoylecgonine
1
50
1-800
Methamphetamine
5
20
5-500
Oxycodone
16
20
16-1000
Buprenorphine (Therapeutic drug)
1.6
10
1.6-500
a
Regulatory level is that set by State of Indiana.
Drugs

Metabolites

Therapeutic
range
(ng/mL)
10-100
N/A
50-930
N/A
10-50
10-100
14-110

LOQs achieved for all the drugs or metabolites tested are adequate for screening and
therapeutic monitoring purposes, except for oxycodone. A relatively high background
signal was observed when monitoring the fragment ions m/z 298 or 241 generated in
MS/MS transitions for both oxycodone and the IS oxycodone-d6. The interference is most
likely caused by the chemical compounds mixed in the paper during manufacture, which
might include oxycodone as well at trace levels. Various methods for treating the paper
prior to use for the PS-MS have been explored to eliminate the chemical interference. It
was found that treating the chromatography paper with HNO3 or NaClO aqueous solution
was effective. To perform this treatment, the 31 ET (Whatman, Maidstone, UK) paper was
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immersed into 10-3 M HNO3 aqueous solution or NaClO aqueous solution (Cl% = 1.5 g/L,
pH = 12) in 45 °C for 3 hours and then was washed for six times using water. The paper
was dried at 70 °C for 2 hours and stored for later use in DBS preparation and the PS-MS
analysis (Figure 2.6).

Figure 2.6

Schematic representation of paper treatment for the PS-MS.

MS and MS/MS spectra were recorded for the blank paper substrates using the
Exactive Orbitrap and the TSQ, respectively, before and after the treatments (Figure 2.7).
As shown in Figure 2.7 A, many peaks in the MS spectra and relatively high intensities at
the m/z values for the fragmentation ions m/z 298 and 241 were observed for the untreated
paper. Although fewer peaks were observed in the MS spectra after the paper was washed
with water, intensities at the m/z 298 and 241 in the MS/MS spectra did not decrease
sufficiently (Figure 2.7 B). After the treatments with HNO3 or NaClO aqueous solution,
the chemical noise in both the MS and MS/MS spectra was significantly reduced. The
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comparison of chemical interference was also made with blood samples without oxycodone
(Figure 2.8) and similar improvement was observed with the treated paper substrates.

Figure 2.7 Mass spectra (mass range: m/z 200-1000) by the Orbitrap and MS/MS spectra
(parent ion: m/z 316.1, mass range: 297.0-299.0 and 240.0-242.0) by the TSQ for blank
paper substrates subject to different treatments. (A) untreated 31 ET paper, (B) 31 ET paper
washed with water, (C) 31 ET paper treated with 10-3 M HNO3 aqueous solution and (D)
ET paper treated with NaClO aqueous solution (Cl% = 1.5 g/L, pH=12). Paper spray
solvent: 90% acetonitrile: 10% water solution; solvent volume: 25 μL; Voltage: 3.5 kV.
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Figure 2.8 Mass spectra (mass range: m/z 200-1000) by the Orbitrap and MS/MS spectra
(parent ion: m/z 316.1, mass range: 297.0-299.0 and 240.0-242.0) by the TSQ for blank
DBS subject to different treatments. (A) untreated 31 ET paper, (B) 31 ET paper washed
with water, (C) 31 ET paper treated with 10-3 M HNO3 aqueous solution and (D) ET paper
treated with NaClO aqueous solution (Cl% = 1.5 g/L, pH=12). Paper spray solvent: 90%
acetonitrile: 10% water solution; solvent volume: 25 μL; Voltage: 3.5 kV.
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Figure 2.9 (A) Comparison of signal-to-noise ratio of 100 ng/mL of benzoylecgonine
(Ben), oxycodone (Oxy) and buprenorphine (Bup) before and after treatment by 10 −3 M
HNO3 aqueous solution or NaClO aqueous solution. Calibration curves of oxycodone in
DBS on the 31 ET paper (B) without treatment, (C) treated by 10−3 M HNO3 aqueous
solution and (D) treated by NaClO aqueous solution (Cl% = 1.5 g/L, pH = 12).

The potential improvement in quantitation of the abused drugs in blood was evaluated
using oxycodone (Oxy), benzoylecgonine (Ben) and buprenorphine (Bup). In each case,
the fragment ion intensity was measured for a DBS with 100 ng/mL drug compounds and
a blank DBS sample using the untreated and treated paper substrates to obtain S/N values
for comparison. As shown in Figure 2.9 A, the largest improvement was observed for
benzoylecgonine, with about a 16-fold increase. The MS/MS transition of m/z
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316.1→241.0 was used for oxycodone and an 8-fold improvement in S/N was obtained.
The improvement in quantitation with the treated paper substrates was also characterized
using these three drug compounds. The lower end of the calibration curves for oxycodone
are shown in Figure 2.9 B-D for comparison. LOQs of 1.0 ng/mL and 0.9 ng/mL were
achieved with the paper substrates treated with HNO3 and NaClO, respectively. This is
adequate for quantitative analysis for therapeutic monitoring purposes (Table 2.2).

2.4

Conclusion

In this section, a simple method for both fast screening and quantitative determination
of abused drugs and therapeutic drugs in DBS was developed by paper spray mass
spectrometry. Drugs could be directly extracted, identified and quantified without any pretreatment or separation. The composition of solvent and the size of the blood spot were
important in determining the signal intensity in paper spray mass spectrometry. Internal
standards were used in the quantitation of all the drugs of abuse and the approach to loading
internal standard significantly affected the quantitation result. The ranges of quantitation
were sufficient to cover the screening range of abused drugs and metabolites with good
linearity (R2>0.99) and acceptable reproducibility (RSD≈12%). In addition, a simple
treatment of the paper using HNO3 or NaClO was developed to improve the quantitative
performance via eliminating the matrix effect of small molecules in the paper. The signalto-noise ratios of benzoylecgonine, oxycodone, and buprenorphine were increased by
about 16 times, 8 times and 2 times, respectively, after the treatment. The limits of
quantitation were also obviously improved to be lower than the cut-off level of the
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confirmation screening of oxycodone. Paper spray mass spectrometry has great potential
as an alternative method in the quick monitoring of drug abuse.
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RAPID IDENTIFICATION AND ASSAY OF MULTI-CLASS
ANTIMICROBIAL RESIDUES IN FOOD OF ANIMAL ORIGIN BY PAPER
SPRAY MASS SPECTROMETRY

3.1

Introduction

Antimicrobial misuse is increasingly becoming a world-wide problem that leads to
serious risks to human health, for example, by promoting allergic reactions or creating
drug-resistant bacteria such as the fatal “superbugs”.1-3 Inappropriate use of antimicrobials
in the animal husbandry is one of the major concerns for the antimicrobial usage, since the
residual antimicrobials can be taken involuntarily by human through the daily food.4 The
restriction of maximum residue limits (MRLs) for antimicrobial residues in food were
established by Council Regulation 2377/90/EEC.5 The enforcement of the regulation for
the food safety relies on effective monitoring of antimicrobial residues in the food stuffs.
Microbiological assay as a traditional technique is often used in screening of
antimicrobial residues due to its low cost.6, 7 However, further confirmation is required by
other analytical techniques with better selectivity and sensitivity.8 Quantitative mass
spectrometry (MS) analysis is a powerful tool for monitoring antimicrobial residues in
food.9 Highly specific chemical information is available at high sensitivity by MS coupled
with the liquid chromatography (LC) or the gas chromatography (GC), which have become
golden standards for the antimicrobial residue monitoring required by the Food and Drug
Administration of USA as well as public health organizations in other countries.10, 11 In the
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GC-MS or LC-MS, the sample preparation plays an important role in achieving high
sensitivity and accuracy of the quantitation. Taking the meat as an example, the sample
preparation before the LC-MS analysis typically includes homogenization, filtration,
evaporation at reduced pressure, solid phase extraction, evaporation, and re-dissolution.12,
13

Large batches of samples can be prepared in parallel following this type of multiple-step

procedures. However, the time and expertise involved for the analysis of a single sample
prevented this method from being applied by non-expert outside the analytical laboratories.
Recently, ambient mass spectrometry has been developed for executing single-step
analysis of target analytes in complicated matrices with minimum sample preparation.14
Over the past decades, a number of ambient ionization techniques were developed to
rapidly screen antimicrobials in the food in its original state, such as desorption
electrospray ionization (DESI),15,

16

direct analysis in real time (DART),17 desorption

atmospheric pressure chemical ionization (DAPCI),18 desorption atmospheric pressure
photoionization (DAPPI),19 infrared laser assisted desorption electrospray ionization (IRLADESI),20 infrared laser ablation metastable-induced chemical ionization (IRLAMICI),21 desorption electrospray/metastable-induced ionization (DEMI), 22 and so forth.
Recently, paper spray mass spectrometry (PS-MS) has been developed as an ambient
ionization MS method for direct and quantitative analysis of target analytes in complex
samples.23, 24 In a typical PS-MS analysis, a small amount of sample is deposited on a paper
substrate of a triangle shape; then the analytes are eluted from the sample by a solvent,
which subsequently spray ions for MS analysis with a high voltage applied on the wetted
substrate. It has been demonstrated that a highly efficient analyte extraction can be
achieved with the paper spray in a high sensitivity, which the LOQ better than 1 ng/mL
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was obtained for the therapeutic drugs monitoring in the whole blood.25 As a result, the
analysis efficiency can be significantly improved with PS-MS by simplifying the
operations while achieving satisfactory qualitative and quantitative performance. This
technique has been successfully applied in the quantitation of therapeutic and illicit drugs,25,
26

food contaminants,27 as well as biomarkers for the new-born screening.28 A wide range

of applications has been demonstrated for practical analysis. In this work, we utilized the
PS-MS to identify and quantify nine antimicrobial residues in four antimicrobial families
from four kinds of general food sample matrices, including beef, chicken meat, milk, and
egg. The results of this study suggest a great potential for applying the PS-MS in
monitoring of antimicrobial residues in food industry.

3.2
3.2.1

Materials and methods
Reagents and instrument

Acetonitrile, acetone, methanol and formic acid (HPLC-grade) were obtained from
Mallinckrodt Baker (Phillipsburg, NJ, USA). Deionized water was produced by a Millipore
Ultrapure Water Purifier (Billerica, MA, USA). Marbofloxacin, difloxacin, lincomycin,
clindamycin, amoxicillin, penicillin-G, cloxacillin, minocycline, and chlortetracycline
were purchased from Sigma (St. Louis, MO, USA). Grade 1 paper was obtained from
Whatman (Maidstone, England). Beef, chicken meat, milk, and egg were purchased from
a local supermarket. All the data were collected by TSQ Quantum Access Max or LTQ
linear ion trap mass spectrometer mass spectrometer (Thermo Scientific, CA, USA).
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3.2.2

Standard stock solution preparation

1.0 mg/mL stock solutions of marbofloxacin, difloxacin, lincomycin, clindamycin,
amoxicillin, penicillin-G, cloxacillin, minocycline, and chlortetracycline were prepared by
dissolving 1.00 mg of powders into 1000 μL of methanol solution, respectively. Each
solution was vortexed and stored at –20 oC for an extended period of time without any
issues.
3.2.3

Working solution of beef or chicken meat samples.

Organic beef or chicken meat each of 2.0 g was collected in a 50 mL centrifuge tube,
and was homogenized with 10 mL deionized water for half an hour. The homogenates were
then stored at -20oC for future use. The standard working solution at 50.0 mg/kg was made
by spiking 10.0 μL of 1.0 mg/mL stock solution into 990 μL blank meat homogenate of
beef or chicken. The working solution was further diluted to 5.0 mg/kg by adding 100 μL
50.0 mg/kg working solution into blank homogenate of 900 μL. A series of standard
samples at lower concentrations were prepared by gradual dilution with the blank
homogenate.
3.2.4

Working solution of milk or egg

The white of an egg was separated from the yolk and stored in a fresh tube at 4 oC for
future use. The organic whole milk was stored at 4 oC and directly used without any
preparation. The standard working solution at 500.0 mg/kg was prepared by spiking 5.0 μL
of 1.0 mg/mL stock solution into 10.00 mg of the whole milk or the egg white. The working
solution was further diluted into 5000.0 μg/kg by adding 10 μL of 500.0 mg/kg working
solution into blank sample matrix of 990 μL. A series of standard samples at lower
concentrations were prepared by gradual dilution with the blank milk or the egg white.
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3.3

Results and discussions

Food matrices contain a variety of chemical compounds of different chemical
properties, which certainly cause severe matrix effects in MS analysis of antimicrobial
compounds. In the past, the PS-MS has shown to be effective in eliminating the matrix
effect for analysis of drug compounds in the blood, urine, and tissue samples. In this study,
the PS-MS was applied for direct detecting antimicrobial residues at low levels in food
samples.

Figure 3.1

Schematic representation of paper spray mass spectrometry.

The instrumentation and the procedure for the PS-MS have been described
previously.29 As shown in Figure 3.1, a piece of paper was first cut into a triangle (5 mm
base × 10 mm height). Sample solution of 2.0 μL was directly deposited onto the paper
substrate. The paper substrate was held by a metal clip with a distance of 7 mm between
the paper tip and the MS inlet. A solvent of 15.0 μL was then deposited onto the paper to
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Table 3.1

Tandem mass spectrometric parameters for paper spray.

Drug

Ion
Mode

Marbofloxacin

+

Precursor ion
(m/z)
363.02
[C17H19FN4O4+H]

+

Collision
Product ion
Tube
Reference energy
lens
(m/z)
(V)
345.01
30
+
19
85

[C17H17FN4O3+H]

356.07
Difloxacin

+

19

[C20H19F2N3O+H]+

400.05

30

[C21H19F2N3O3+H]+

382.13

29

[C21H17F2N3O2+H]+

Lincomycin

+

Clindamycin

+

Amoxicillin

+

Penicillin-G

-

Cloxacillin

-

Minocycline

+

Chlortetracycline +

407.09

126.04

[C18H34N2O6S+H]+

[C8H16N+H]+

425.07

126.05

[C18H33ClN2O5S+H]+

[C8H16N+H]+

366.00

349.01

[C16H19N3O5S+H]+

[C16H17N2O5S+H]+

333.27

192.05

[C16H18N2O4S-H]

-

434.20
[C19H18ClN3O5S-H]-

31

34

79

32

28

88

33

10

94

34

17

81

35

16

92

36

29

85

37

20

79

[C10H10NOS]-

293.20
[C13H8O3N2ClH+H2O]-

458.10

440.95

[C23H27N3O7+H]+

[C23H24N2O7+H]+

478.98

444.12

[C22H23ClN2O8+H]+ [C22H18ClNO7+H]+
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elute the analyte from the dried sample spot. A DC voltage of 3.5 kV was applied through
the metal clip from the base of the paper substrate, which facilitated the spray ionization
from the tip of the paper. The identification of each antimicrobial in different food matrices
was carried out using a TSQ Quantum Access Max or LTQ linear ion trap mass
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spectrometer (Thermo Scientific, CA, USA) in the product ion mode. In this mode,
precursor ions of each antimicrobials were isolated and dissociated to form fragments by
CID, which were characteristic for identity confirmation. The quantitation of each
antimicrobial was realized by using multiple reaction monitoring (MRM). MS parameters
for the detection of antimicrobials, including tube lens, skimmer lens, and collision energy
(CE), were tuned in the automatic tuning mode with infusion of pure antimicrobial sample
and nano electrospray ionization. The MS/MS transitions and CID conditions are provided
in 错误!未找到引用源。.

3.3.1

Optimization of extraction and ionization.

The extraction of antimicrobials was spontaneously carried out when 15.0 μL of solvent
was applied from the back edge of the paper substrate. In the process of extraction, the
solvent quickly spread from the back edge to the tip due to the capillary effect. When the
solvent was encountered to the sample, antimicrobials were quickly dissolved and eluted
with the solvent. This process was accelerated by applying 3.5 kV high voltage onto the
paper substrate for electrospray. Since these antimicrobials were distinct in their structures
and properties, the formulation of the solvent was essential to the extraction efficiency and
the ionization efficiency. For example, the selected nine antimicrobials can be classified
into four antibiotic families (quinolone, macrolides, beta-lectams, and tetracycline) based
on the similarities in their bone structures (Figure 3.2), so the corresponding protocols for
LC/MS/MS, especially the formulation of elutes, vary from antibiotic families and food
matrices (Table 3.2).
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Table 3.2

Comparison between LOD of paper spray and maximum residue level (MRL) in council regulation (EEC) No. 2377/90.

Antibiotic
Family

Analyte

Quinolone

Marbofloxacin
Difloxacin

Macrolides

Matrix

MRL
(μg/kg)

15.0
Chicke
n Meat

300

Lincomycin
100

Clindamycin

Milk

Cloxacillin
Tetracycline

4

4.0

4

4.0

30

10.0

Minocycline

12.5
Egg

Chlortetracycli
ne

Solvent of
PS-MS
Methanol: water =
9:1 (v: v), with
formic acid pH=2.0

Acetone: acetonitrile
= 1:1 (v: v) with
formic acid pH=2.0

12.5

Amoxicillin
Penicillin-G

15.0

12.5
Beef

Beta-lectams

LOD of
PS-MS
(μg/kg)

200
6.2

Acetonitrile with
formic acid pH=2.0
Methanol: water = 9:1
(v: v)
Acetonitrile
Acetone: acetonitrile
= 1:1 (v: v) with
formic acid pH=2.0

LOD of
LC/MSMS
(μg/kg)
1.5
0.3

Method in Reference
Extraction, centrifugation,
filtration, online clean-up
using turbulent flow
chromatography38

4.0

Deproteination, extraction,
dryness, defattation,
centrifugation, filtration, and
analysis by LC/MS/MS39

0.2

Extraction, centrifugation,
filtration and analysis by
LC/MS/MS40

0.5
0.5
1.1
5.8

1.3

Vortex, centrifugation,
extraction, SPE, dryness,
filtration and analysis by
LC/MS/MS41
Extraction, dryness, vortex,
filtration and analysis by
LC/MS/MS42
Filtration, micro-SPE,
separation and analysis by
LC/MS/MS43
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Figure 3.2 Schematic representations of the chemical structures of marbofloxacin,
difloxacin, lincomycin, clindamycin, amoxicillin, penicillin-G, cloxacillin, minocycline,
and chlortetracycline, and their pKa values.

It is also evident with our observation that the signal response of the sample was
influenced by the solvent composition. For instance, as shown in Figure 3.3, the intensity
and the stability of signal responses of 100 ng/mL of lincomycin (m/z 407.09 → m/z 126.04)
were significantly different when six kinds of pure solvents (methanol, ethanol, n-butyl
alcohol, acetonitrile, acetone, and ethyl acetate) were applied to the PS-MS, respectively.
Many parameters of the solvent were contributed to this difference and needed to be
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carefully optimized to ensure good performance, such as polarity, saturated vapor pressure,
and pH. As to the polarity, the ideal solvent has a similar polarity as the target molecule,
but has an opposite or different polarity from the matrix. It is because the intermolecular
forces of attraction between the target molecule and solvent is strong if they have similar
polarity. In other words, polar analytes tends to dissolve in polar solvents, and nonpolar
analytes dissolve in nonpolar solvents. In addition, the saturated vapor pressure of the
solvent should also be carefully evaluated to achieve a good ionization efficiency.
Typically, a high saturated vapor pressure leads to a good ionization efficiency. For
example, acetone has a higher saturated vapor pressure (24.64 kPa in 20 oC, 101.24 kPa)
compared to other solvents in the same condition. This property enables higher desolvation
efficiency of sample from eluent to be evaporated as droplets, and also allows a higher
ionization efficiency from big evaporated droplets to dry ions. Apart from above, pKa value
of each antimicrobial is very important for selection of positive/negative ionization mode
as well as the best pH value of the solvent. For example, the pKa value of cloxacillin is 3.8,
which is easier to be ionized in the negative voltage. As a result, negative mode was
selected and the pH value was adjusted to be higher than its pKa to ensure loss of proton
for the ionization. The above principle is also applicable to other antimicrobials. The
composition of solvent for different antimicrobials was listed in Table 3.2. The PS-MS
took only 3 minutes to analyze one sample which saves at least 1 hour for each sample with
adequate performance. This result suggested that the PS-MS is adequate for identification
and quick screening antimicrobials at trace levels from different kinds of complex food
matrices.
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Figure 3.3 The influence of solvent on the signal response of 100 ng/mL of lincomycin
by the PS-MS. Paper substrate: Grade 1 chromatography paper; Voltage: 3.5 kV.

3.3.2

Identification of antimicrobials in food

The identification of antimicrobials was achieved by tandem mass spectrometry
(MS/MS), where characteristic fragment ions were produced as shown in Figure 3.4. The
MS/MS conditions was optimized using 1 μg/mL of pure standard sample of antimicrobial
in the methanol by the nano-ESI. The MS/MS transitions and the optimized collision
energies are listed in Table 3.1, which subsequently were used for direct analysis of the
food samples by PS-MS.
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Figure 3.4 Identification of antimicrobials in different food matrices with Grade 1
chromatography paper by the PS-MS. MS/MS spectrum of (A) difloxacin (m/z 400.05 →
m/z 356.07) and (B) marbofloxacin (m/z 363.02 → m/z 345.01) in chicken meat; (C)
lincomycin (m/z 407.09 → m/z 126.04) and (D) clindamycin (m/z 425.07 → m/z 126.05)
in beef; (E) amoxicillin (m/z 366.00 → m/z 349.01), (F) penicillin-G (m/z 333.27 → m/z
192.05), and (G) cloxacillin (m/z 434.20 → m/z 293.20) in milk; (H) minocycline (m/z
458.10 → m/z 440.95) and (I) chlortetracycline (m/z 478.98 → m/z 444.12) in egg. Sample
volume: 2 µL; Solvent volume: 15 µL; Voltage: 3.5 kV.

109

Figure 3.5 Identification of antimicrobials in different food matrices with Grade 1
chromatography paper by the PS-MS. MS/MS spectrum of (A) 15 μg/kg of difloxacin (m/z
400.05 → m/z 356.07) and (B) 15 μg/kg of marbofloxacin (m/z 363.02 → m/z 345.01) in
chicken meat; (C) 12.5 μg/kg of lincomycin (m/z 407.09 → m/z 126.04) and (D) 12.5 μg/kg
of clindamycin (m/z 425.07 → m/z 126.05) in beef; (E) 4.0 μg/kg of amoxicillin (m/z
366.00 → m/z 349.01), (F) 4.0 μg/kg of penicillin-G (m/z 333.27 → m/z 192.05), and (G)
10.0 μg/kg of cloxacillin (m/z 434.20 → m/z 293.20) in milk; (H) 12.5 μg/kg of
minocycline (m/z 458.10 → m/z 440.95) and (I) 6.2 μg/kg of chlortetracycline (m/z 478.98
→ m/z 444.12) in egg. Sample volume: 2 µL; Solvent volume: 15 µL; Voltage: 3.5 kV.

110
The limit of detections (LODs) were determined by the lowest concentrations at which
the peaks of the characteristic fragment ions could be observed when the food samples
containing the antimicrobials at different concentrations were analyzed. Figure 3.5 shows
the product ion mass spectra of antimicrobials in food samples at their LODs, including
15.0 μg/kg difloxacin and marbofloxacin in chicken meat, 12.5 μg/kg lincomycin and
clindamycin in beef, 4.0 μg/kg amoxicillin and penicillin-G in milk, 10.0 μg/kg of
cloxacillin in milk, 12.5 μg/kg minocycline in egg, and 6.2 μg/kg of chlortetracycline in
egg. Each dried sample spot on paper was prepared by depositing 2.0 μL of liquid sample
or homogenate onto the Grade 1 chromatography paper. As shown in Table 4.2, some
LODs of antimicrobials, such as difloxacin (15 μg/kg in chicken meat), marbofloxacin (15
μg/kg in chicken meat), minocycline (12.5 μg/kg in egg), and chlortetracycline (6.2 μg/kg
in egg) were far below their respective MRLs (300 μg/kg for marbofloxacin and difloxacin
in chicken meat; 200 μg/kg for minocycline and chlortetracycline in egg). This result
showed sufficient capability of PS-MS in monitoring antimicrobial residues in foods.

3.3.3

Quantitation of antimicrobial residue in food

The PS-MS also performed well in quantitation of antimicrobials in food. Figure 3.6
provided the calibration curve of difloxacin (parent ion: m/z 400.05, product ion: m/z
356.07; the x-axis: the concentration of difloxacin, the y-axis: the absolute intensity of the
product ion dissociated from the precursor ion of difloxacin) in the homogenized chicken
meat. Preliminary experiments showed that the MS result changed with the presence or
absence of food matrix. Thus, a matrix-matched calibration curve of difloxacin was
established to compensate for the suppression from matrix effect. For preparing working
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solutions, 10.0 μL of 1.0 mg/mL stock solution of difloxacin was first spiked into blank
chicken meat solution of 990 μL to form a working solution at 50.0 mg/kg. Then, the
solution was further diluted into 5.0 mg/kg by adding 100 μL of 50.0 mg/kg working
solution into 900 μL blank food sample matrix. A series of working standard solutions in
lower concentrations (0, 19.5, 39.1, 78.1, 156.3, 312.5, 625.0, 1250.0, and 2500.0 μg/kg)
were prepared with gradual dilution with homogenized blank sample food solution in the
proportion of one to one. The quantitation was performed in the single reaction monitoring
(SRM) mode by a TSQ Quantum Access Max in the MRM mode. The linear regression
coefficient of the present calibration curve (R2 = 0.9992) demonstrated a good linear
relationship over 3 orders of magnitude in concentration. The sample in each concentration
was tested for 5 replicates. The relative standard deviation of each point was below 17%,
which showed a good reproducibility. The above result suggested that PS-MS has potential
in quick estimation of antimicrobial’s concentration. The performance can be enhanced by
using internal standard as a reference when necessary.

Figure 3.6 Linear dynamic range of difloxacin [(M + H)+, m/z 400.05; product ion, m/z
356.07] in chicken meat by the PS-MS.
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3.4

Conclusion

In conclusion, we demonstrate that the PS-MS is a powerful platform for the practical
analysis of general antimicrobial residues in food. The function of sample storage,
separation and molecule ionization can be integrated with one single commercial
chromatographic paper. Nine antimicrobial residues in four antimicrobial families in four
kinds of matrices (including beef, chicken meat, milk and egg) were analyzed by the PSMS. LODs of all the antimicrobials were all below the MRLs announced by Council
Regulation 2377/90/EEC, which suggests enough capability of paper spray in quick
screening of antimicrobial residues in food. In addition, the quantitative ability of paper
spray also enables quick concentration determination of antimicrobials. These results
indicate the PS-MS’s merits of low cost, simple operation, high throughput, sensitivity and
selectivity. It has potential to be a simple alternative platform to provide a direct and rapid
strategy for quick identification, screening and quantitation of antimicrobial residues in
complex food matrices.
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DIRECT ANALYSIS OF BIOFLUID SAMPLES BY PIPETTE SPRAY
MASS SPECTROMETRY

4.1

Introduction

Drug analysis offers key information to reveal situations and relationships within
living organisms and has played important roles in clinical diagnosis,1 biological
mechanism study,2 quality control of pharmaceutical products,3 forensic analysis,4 food
safety,5 therapeutic drug monitoring,6 and so forth. However, the sensitivity and the
accuracy of the analysis is significantly decreased by interferences from complex
biological matrices.7 This matrix effect is particularly evident for the ionization
suppression during the mass spectrometry (MS) analysis that results in undesired limit of
detection (LOD) or quantitation (LOQ). The instrument may also be contaminated if too
much biological matrix is directly introduced to the mass spectrometer. In order to
overcome this matrix effect, a series of sample preparation and separation techniques have
been developed for achieving high accuracy and high sensitivity of the MS analysis, such
as

liquid-liquid

extraction,8

solid

phase

extraction,9

protein

precipitation,10

preconcentration,11 and chromatography.12 The combination of liquid chromatography (LC)
or gas chromatography (GC) with the MS has been a golden standard used in the drug
analysis from complex matrices.13 Typically, the target molecules are treated in several
steps before the LC-MS or the GC-MS analysis. Large batches of samples can be prepared
in parallel following this type of multiple-step procedures. However, the time and expertise
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required in the analysis of a single sample prevents this method from being applied by nonexpert outside the analytical laboratories.
In order to simplify the sample preparation, a novel concept of ambient mass
spectrometry was proposed in last decade. It records mass spectra on ordinary samples, in
their native environment, without sample preparation or separation by creating ions outside
the instrument.14 A series of milestone ionization methods were developed for direct
biosample analysis, such as desorption electrospray ionization,15 direct analysis in real
time,16 low temperature plasma,17 and so forth.18 These techniques have been used in direct
qualification and quantitation of raw samples,19 on-line reaction monitoring,20 as well as in
vivo tissue imaging of target molecules in complex biological matrices with very high
sensitivity.21 The simple operation procedure and good analytical performance of ambient
ionization methods allow MS techniques to be applied in the development of point-of-care
(POC) for in situ diagnosis or chemical analysis in combination with portable Mini-MS.22
In addition to the simple operation, some ambient ionization methods show excellent
quantitative performance in some applications with mandatory LOQs and mandatory
precisions, such as drug monitoring in biofluids for forensic use and additive monitoring
in cosmetics for skin safety.23 Recently, paper spray mass spectrometry (PS-MS) has been
developed for direct and quantitative analysis of the target analyte in complex samples.24
In a typical PS-MS analysis, a small amount of sample is deposited onto a paper substrate
of a triangle shape; then the analytes are eluted from the sample by a solvent, which are
subsequently ionized for the MS analysis with a high voltage applied on the wetted
substrate. A significant reduction of matrix effect can be achieved with the paper spray
with a high sensitivity, so that the LOQ better than 1 ng/mL can be obtained for the
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therapeutic drug monitoring in the whole blood.4 As a result, the analytical efficiency can
be significantly improved with the PS-MS by simplifying the operations as well as
achieving satisfactory qualitative and quantitative performance. This technique has been
successfully applied in a wide range of practical applications: quantitation of therapeutic
and illicit drugs,4, 25 food contaminants,26 and biomarkers for the new-born screening.27
During the PS-MS analysis, a series of factors have been reported to significantly affect
its quantitative performance, which presents great potentials to achieve higher sensitivity
through more innovations of the design. For example, the thinner paper was found to have
a better sensitivity because the thinner paper produced a sharper tip to form smaller droplets
during the spraying process.28 The development of extraction spray significantly improved
the sensitivity for analyzing therapeutic drugs in blood samples by inserting a paper strip
with the dried blood spot into a nano-ESI tube for spray.29 However, the operation is
complicated in the step of inserting the paper strip. In addition, developing an effective
way to add internal standards (IS) in small amounts without requiring laboratory skills is
still a major challenge for applications of POC and other customer-directed devices.30
In this study, pipette spray as a new version of paper-based extraction and ionization
device was developed for direct identification and quantitation of analytes in complex
biological samples. A piece of Grade 1 chromatography paper was cut into squares with
sides 4 mm in length and was inserted into a pipette tube with a nano-ESI tip. The cartridge
design facilitates the fabrication and usage, so that the extraction and ionization of analytes
could be simply accomplished by sequentially applying 1-10 μL biological sample, 10 μL
solvent, and 1.5 kV high voltage on the paper substrate within 1 minute. Excellent limit of
quantitation as low as 0.5 ng/mL was achieved for analyzing methamphetamine in the
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whole blood with good reproducibility (RSD<10%), which was significantly improved
compared to the PS-MS. The spray time achieves to 40 minutes in very stable signal
intensity that suggests reliable and stable results for the quantitative analysis. Furthermore,
the IS was homogeneously preloaded and confined in the paper substrate that allowed the
quantitation to be completed with high sensitivity and accuracy and with minimal lab skills.
The robustness of this method has been demonstrated for antibiotic monitoring in milk and
drug abuse monitoring in whole blood, which are in great need of fast and reliable
quantitative analysis platform for protecting human health and social security.

4.2

Materials and instrumentation

Acetonitrile, acetone, methanol, and formic acid (HPLC-grade) were obtained from
Mallinckrodt Baker (Phillipsburg, NJ, USA). Deionized water was produced by a Millipore
Ultrapure Water Purifier (Billerica, MA, USA). Marbofloxacin, difloxacin, lincomycin,
clindamycin,

penicillin-G,

cloxacillin,

minocycline,

methamphetamine,

and

chlortetracycline were purchased from Sigma (St. Louis, MO, USA). Methamphetamined8 was procured from the Cambridge Isotope Laboratories, Inc. (Cambridge Isotope
Laboratories, Inc., Tewksbury, MA). Samples of different concentrations (0.1-1000 ng/mL)
were prepared by gradual dilution with the bovine blood (Innovative Research Inc., Novi,
MI) or the milk (local supermarket). 31 ET and Grade 1 paper were bought from Whatman
(Maidstone, England).
The cartridge of the pipette spray was fabricated by cutting the chromatography paper
into squares with sides 4 mm long and was inserted into a pipette tube with a nano-ESI tip.
Blood or milk sample of 1-10 μL was collected and stored in the form of a dried spot on
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the paper substrate. For the MS analysis by pipette spray, 10 μL solvent was applied and
drenched the paper for 1 minute to sufficiently extract analytes from the biosample spot.
The extract was spontaneously delivered to the tip by shaking the cartridge.

A DC voltage

of 1.5 kV was applied through the metal clip from the base of the paper substrate, which
facilitated the spray ionization from the tip of the paper. The MS spectra were recorded
using an TSQ Quantum Access Max mass spectrometer (Thermo Scientific, CA)

Figure 4.1

Schematic representation of pipette spray mass spectrometry

4.3

Results and discussions

Biofluids contain a variety of chemical compounds of different chemical properties,
which certainly cause severe matrix effects in the MS analysis of analyte. In the past, the
paper substrate has shown to be effective in eliminating the matrix effect for analysis of
drug compounds in the blood, urine, and tissue samples.31 In addition, the nano-ESI also
shows excellent ionization efficiency and stability due to its sharp tip in the nano meter
scale. In this study, the pipette spray integrates these advantages within a pipette tube and
was applied for direct drug monitoring at low levels in biofluids. In order to fabricate a
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pipette spray cartridge, the Grade 1 chromatography paper was cut into small squares (4
mm×4 mm) and inserted into a pipette tube with a nano-ESI tip 6 mm in length. After
coated with corresponding ISs of target analytes in the paper substrate, these cartridges
were arranged in the 96-well plate for the future use in the drug monitoring in biofluids.
The design of disposable sample cartridges simplified the fabrication process, prevented
possible cross-contamination, and streamlined the analysis protocol without use of
traditional lab skills. The MS analysis can be completed in one step within one minute by
applying the solvent and high voltage to the cartridge loaded with the biological sample.
Therefore, this fast extraction allowed the drug monitoring to be highly efficient to meet
with the challenge of the real applications with large amount of samples, such as emergent
clinical diagnosis, food safety screening in the supermarket, and security checks in the
customhouse. The following discussion will focus on two processes during this one-step
operation: (1) extraction of the analyte from the biological sample and (2) ionization of the
analyte for the MS analysis.
4.3.1

Extraction of analyte by the paper substrate

In the previous study, clogging frequently occurred if biofluids were directly injected
into the nano-ESI tube because cells tended to accumulate into clusters in microliters of
diameters in the tip.32 In addition, these matrices also suppressed the ionization of the target
analyte, rendering low sensitivity of the MS analysis. The mass spectrometer may even be
contaminated if too much biological matrices are introduced to the instrument. In the
pipette spray, the paper substrate was used as a filtration and separation device sharing the
same principle as the PS-MS, viz. large molecules are blocked in the paper fibers, while
small molecules can freely pass through the paper fibers and achieve to the electrospray tip
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through fast extraction. The affinity of molecules to the paper fiber also affects the elution
of the molecules. Therefore, the selection of the paper substrate is very important for
reducing the matrix effect and increasing the drug extraction efficiency. Figure 4.2
compares the extraction of 100 ng/mL difloxacin (m/z 400.05 → m/z 356.12 and m/z 382.23)
from dried milk spots each prepared with 1 μL whole milk in different paper substrates.
The signal-to-noise ratios (S/N) of product ions m/z 356.12 and m/z 382.23 were used to
evaluate the performance of the extraction. The highest S/N was achieved by the Grade 1
chromatography paper, which was possibly because Grade 1 chromatography paper was
the thinnest and required less solvent to be trenched, so the concentration of the target
analyte in the extract was higher.

(A)

(B)

(C)

Figure 4.2 Effect of paper substrate on sensitivity of pipette spray mass spectrometry.
MS/MS spectrum of difloxacin [(M+H)+, m/z 400.05; product ion, m/z 356.12 and m/z
382.23] that is extracted from whole milk on the (A) cotton, (B) Grade 1 chromatograph
paper, and (C) ET-31 paper as the paper substrate. Extraction solvent: 90% methanol/10%
water/1% acetic acid (v/v/v), 10.0 μL. Voltage: 1.5 kV.

Based on the above assumption, the signal intensity of difloxacin should be higher
when more sample was loaded on the paper substrate. Interestingly, however, the result
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showed a reversed trend when difloxacin was loaded in three amounts (1.0 μL, 5.0 μL, and
10.0 μL) onto the Grade 1 paper in the same size for the pipette spray as shown in Figure
4.3. This is because a higher ratio of biological matrix can be blocked in paper fibers with
a decrease of the sample amount, so that more analyte can be ionized without suffering
from the ion suppression of the biomatrix. Therefore, the paper substrate is very important
for decreasing the matrix effect, and the choice of the sample amount should consider
factors of sample concentration and matrix effect.

(A)

(B)

(C)

Figure 4.3 Effect of the sample amount on the sensitivity of pipette spray mass
spectrometry. MS/MS spectrum of 100 ng/mL difloxacin [(M+H)+, m/z 400.05; product
ion, m/z 356.12 and m/z 382.23] in (A) 1 μL, (B) 5 μL, and (C) 10 μL whole milk extracted
on the Grade 1 chromatography paper. Extraction solvent: 90% methanol/10% water/1%
acetic acid (v/v/v), 10.0 μL. Voltage: 1.5 kV.

The importance of sample purification by paper substrate was also demonstrated by
another interesting phenomena that the sensitivity of the pipette spray were different when
the sample was loaded in different ways. One way was to let 5.0 μL milk sample of
difloxacin spread spontaneously on the paper to form a spot, the other was loading the
sample from one edge of the paper in a smaller area. As shown in Figure 4.4, the sensitivity
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in the first method was better the second one because higher percentage of the biological
matrix was retained on the paper, so the matrix effect was decreased. At the same time,
since large molecules were blocked by the paper fibers, and small drugs in the first case
were able to go through the matrix to spread further on the paper substrate, these small
drugs can be easily extracted in the solvent. While in the second case, small drugs were
homogenously blocked by the matrix, so they cannot be extracted as free drugs when the
solvent was applied.

(A)

(B)

Figure 4.4 Effect of the method of loading biofluids on the sensitivity of pipette spray
mass spectrometry. MS/MS spectrum of 100 ng/mL difloxacin [(M+H)+, m/z 400.05;
product ions, m/z 356.12 and m/z 382.23] when 5.0 μL milk sample was (A) applied in the
center of the paper to form a spot through spontaneous spread and (B) applied from one
edge of the paper to be concentrated in a smaller area of the paper.

In the quantitative analysis, the way of loading internal standards significantly affects
the sensitivity and accuracy of the result. Typically, there are two ways to load internal
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standards: (1) premixing internal standards in biofluids and (2) preloading internal
standards on a paper substrate before directly spiking biofluids on the paper. Compared to
the premixing method, the preloading method requires little analytical lab skill so that it
can be easily used by common customers for in situ POC analysis. However, its
quantitative performance, viz. the accuracy, precision, and sensitivity are significantly
decreased because the water solution of internal standards forms larger spots than biofluids
in the same volume. Resulting from unmatched sizes between the internal standard spot
and the biofluid spot, internal standards cannot sufficiently mix with the analyte in
biofluids that more free internal standard molecules are extracted in the solvent due to less
blockage by the biological matrix. Large variation of unmatched sizes also decreases the
precision of the preloading method, rendering less accuracy and sensitivity in the
quantitative analysis. In order to overcome these shortcomings of the preloading method,
an internal-standard-coated capillary sampler was developed that significantly improved
the sensitivity and precision by mixing the internal standard with biofluids when biofluids
passed through the sampling capillary. The mixed biofluids were then spiked on the paper
for analysis.30 In the pipette spray, a new strategy was developed to improve the
quantitative performance of the preloading method. A very small piece of paper (4 mm ×
4 mm) was used as a premixing and extraction device that can be homogeneously covered
by 5.0 μL biofluids or the internal standard water solution. As a result, the internal standard
spot and the biofluid spot can be perfectly matched in sizes for sufficient mixing and
synchronous extraction in the preloading method. The initial test of this preloading method
was achieved with the analysis of methamphetamine (m/z 150.1→m/z 91.1) in the whole
human blood. After coating 5.0 μL methamphetamine-d8 (m/z 158.1→m/z 93.1) on the
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paper substrate as the internal standard, 5.0 μL whole human blood samples containing
methamphetamine was directly spiked in a pipette spray cartridge and spontaneously
spread over the whole paper substrate. The methamphetamine-d8 and methamphetamine
were mixed during the extraction process when 10.0 μL methanol with 2% acetic acid was
applied into the cartridge. After the paper was drenched for 1 minute, the extract was
delivered to the tip by shaking the cartridge.

Figure 4.5 Effect of the method of loading internal standard on the quantitative
performance of pipette spray mass spectrometry. Linear dynamic ranges obtained for
methamphetamine [(M+H)+, m/z 150.10; product ions, m/z 91.1] in the whole human blood
using 100 ng/mL methamphetamine-d8 [(M+H)+, m/z 158.10; product ions, m/z 93.1] as
IS by (A) the premixing method and (B) the preloading method.

In order to evaluate the quantitative performance of the pipette spray, calibration curves
were established by gradual dilution of the methamphetamine solution by the whole human
blood into a set of samples at concentrations of 0, 0.1, 5, 10, 50, 100, 500 ng/mL with
internal standard methamphetamine-d8 that was (1) premixed with the blood sample to
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keep its concentration at 100 ng/mL or (2) preloaded on the paper substrate with 5.0 μL
100 ng/mL methamphetamine-d8 (Figure 4.5). LOQs of 0.1 ng/mL and 0.5 ng/mL were
achieved in the premixing and the preloading methods, respectively, which had 50-folds
and 10-folds improvement than the paper spray using the premixing method as described
in the chapter 2. LOQs was calculated as the concentration of the drug when the signal-tonoise ratio was equal to 5 at the same m/z value in the MRM mode. Good linearity of the
calibration curve (R2 > 0.989) was obtained over 4 orders of magnitude, which was
sufficient to cover the whole monitoring range of methamphetamine (10-50 ng/mL) for
drug abuse screening and therapeutic purposes. An RSD smaller than 10% was obtained
across the entire linear range. Therefore, accurate quantitation can be achieved by the
pipette spray in both the premixing and preloading method. Since the internal standard and
the analyte were mixed in a precisely confined area, the quantitative performance of the
preloading method was obviously improved without using traditional skilled lab
procedures. This is significant for the application of MS in the POC analysis.

Figure 4.6 Effect of spray solvent on the signal intensity of difloxacin [(M+H)+, m/z
400.05; product ions, m/z 356.12 and m/z 382.23].
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In addition, the composition of solvent is another important factor in the process of
extraction and ionization.33 Take analyzing difloxacin (m/z 400.05 → m/z 356.12 and m/z
382.23) in whole milk as an example. Five pure organic solvents consisting of methanol,
ethanol, acetonitrile, acetone, and ethyl acetate were tested through one-step extraction of
difloxacin in dried milk spots by applying 10.0 μL solvent on the Grade 1 chromatography
paper substrate of the pipette spray cartridge. As shown in Figure 4.6, the highest signal
intensity occurred with the use of methanol as the extraction and spray solvent.

4.3.2

Discussion about the ionization of analyte

In the previous study of the PS-MS, thinner paper performed a better sensitivity because
it produced a shaper tip to form smaller droplets during the spraying process, and smaller
droplets can generate more dry ions that means a higher ionization efficiency. Nano-ESI
has been demonstrated as a very sensitive ion source due to its sharp tip.34 The integration
of the paper substrate as a extraction device with the nano-ESI tip as the ion source has
been demonstrated as a sensitive ambient ionization method for direct quantitation of
biological samples.35 The advantage of this combination was also evident in the pipette
spray. Figure 4.7 shows typical tandem mass spectra of difloxacin (m/z 400.05 → m/z
356.12 and m/z 382.23) extracted from dried milk spots by the PS-MS and pipette spray,
respectively. Each dried milk spot was prepared with 1.0 μL whole milk sample on the
Grade 1 chromatography paper. A mixture of 90% methanol/10% water/0.1 acetic acid
(v/v/v) was used as the extraction and spray solvent. The S/Ns of fragment ions m/z 356.12
and m/z 382.23 from difloxacin had 6-folds and 8-folds increase by the pipette spray than
the PS-MS in the same condition, respectively. In addition, pipette spray required much
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lower voltage (1.5 kV) due to smaller diameter of the nano-ESI tip as well as less extraction
solvent (10.0 μL) for extraction due to smaller paper substrate used in the pipette spray.

Figure 4.7 MS/MS spectrum of 100 ng/mL difloxacin [(M+H)+, m/z 400.05; product ions,
m/z 356.12 and m/z 382.23] extracted from dried milk spots by (A) paper spray with 3.5
kV high voltage and 15.0 μL 90% methanol/10% water/1% acetic acid (v/v/v) solution, as
well as (B) pipette spray with 1.5 kV high voltage and 10.0 μL 90% methanol/10% water/1%
acetic acid (v/v/v) solution. Each dried milk spot was prepared with 1.0 μL whole milk
sample on the Grade 1 chromatography paper.

In addition to high sensitivity, the stability and the spray time were also enhanced by
integrating the nano-ESI tip in the pipette spray. As shown in Figure 4.8, the spray time
can achieve to 40 minutes with very stable signal intensity when 20.0 μL solvent (90%
methanol/10% water/1% acetic acid (v/v/v)) was applied to the pipette spray cartridge for
analyzing 100 ng/mL difloxacin (m/z 400.05 → m/z 356.12 and m/z 382.23) in the dried
milk spot prepared with 1.0 μL whole milk sample. The stable signal intensity was of
significant use for the quantitation of biofluids containing analytes in trace levels in the
MRM mode, by which the intensities of the internal standard and the analyte are
alternatively measured with a time delay. The longer spray time also allowed more data
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points to be collected for averaging signals, so that the quantitative result was more
accurate and precise.

Figure 4.8
Ion chronograms recorded using TSQ Quantum Access Max mass
spectrometer with MRM transition m/z 400.5→382.2 and 356.1 for 100 ng/mL difloxacin
in the whole milk. Solvent: 20.0 μL 90% methanol/10% water/1% acetic acid (v/v/v)
solution; High voltage: 1.5 kV.

4.3.3

Antimicrobial monitoring by pipette spray mass spectrometry

Antimicrobial misuse is increasingly becoming a world-wide problem that leads to
serious risks in human health, for example, by promoting allergic reactions or creating
drug-resistant bacteria such as the fatal “superbugs”.36 Inappropriate use of antimicrobials
in milk is one of the major concerns for the antimicrobial usage, since the residual
antimicrobials can be taken involuntarily by human through the daily food.37 The
restriction of maximum residue limits (MRLs) for antimicrobial residues in milk were
established by Council Regulation 2377/90/EEC.38 The enforcement of the regulation for
food safety relies on the effective monitoring of antimicrobial residues.
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In order to determine the antimicrobials in the milk, the Grade 1 chromatography
paper was cut into small squares (4 mm × 4 mm) and inserted into a pipette tube with a
nano-ESI tip 6 mm in length. These cartridges were arranged in the 96-well plate, so that
1.0 μL milk samples can be easily loaded in cartridges with individual addresses (Figure
4.9). After protein precipitation with 1.0 μL acetonitrile in each cartridge, the milk sample
was quickly dried to form dried milk spot on the paper, which greatly stabilized the sample
and reduced the matrix in the milk. The MS analysis can be completed in one-step within
one minute by applying the solvent and high voltage to the paper substrate in the cartridge.
Therefore, this efficient extraction allowed high-throughput antimicrobial monitoring in
real applications with large amount of samples. The design of disposable sample cartridges
also simplified the fabrication process, prevented possible cross-contamination, and
streamlined the analysis protocol without use of traditional lab skills.

Figure 4.9

Schematic workflow of antimicrobial monitoring by pipette spray mass
spectrometry
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The identification of drugs in biomatrices was carried out using a TSQ Quantum
Access Max (Thermo Scientific, CA, USA) in product ion mode. In this mode, the
precursor ion of each drug was isolated and dissociated to form fragments by the collisioninduced dissociation (CID), which were used to determine the identity of each drug (Figure
4.10). The tandem mass spectrometry (MS/MS) conditions were optimized using 1 μg/mL
pure standard samples in methanol by the traditional nano-ESI method. MS/MS transitions
and optimized collision energies were listed in Table 4.1, which were subsequently used
for direct analysis of biofluids in the pipette spray.

Figure 4.10 Identification of drugs in biomatrices by pipette spray mass spectrometry.
MS/MS spectrum of (A) difloxacin (m/z 400.05), (B) marbofloxacin (m/z 363.02), (C)
lincomycin (m/z 407.09), (D) cloxacillin (m/z 434.20), and (E) chlortetracycline (m/z
478.98) in the whole milk. (F) MS/MS spectrum of methamphetamine (m/z 150.09) in the
whole bovine blood. Sample volume: 5 µL; Solvent volume: 10 µL; Voltage: 1.5 kV.
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Table 4.1

Tandem mass spectrometric parameters for pipette spray mass spectrometry.

Drug

Ion
Mode

Precursor ion
(m/z)

Product ion
(m/z)

363.02
Marbofloxacin

+

[C17H19FN4O4+H]

Reference

345.01
+

[C17H17FN4O3+H]

+

39

356.07
Difloxacin

+

400.05
[C21H19F2N3O3+H]+

[C20H19F2N3O+H]+

407.09

126.04
[C8H16N+H]+

-

434.20
[C19H18ClN3O5S-H]-

Chlortetracycline

+

478.98
[C22H23ClN2O8+H]+

Methamphetamine

+

Cloxacillin

85

19

382.13

[C18H34N2O6S+H]+

+

19

39

89
29

[C21H17F2N3O2+H]+

Lincomycin

Collision
Tube
energy
lens
(V)

40

34

79

293.20
[C13H8O3N2Cl
-H+H2O]-

41

16

92

444.12
[C22H18ClNO7+H]+

42

20

79

24

69

24

69

150.1

91.1

[C10H15N+H]+

[C7H6+H]+
43

Methamphetamined8

+

158.1
[C10H7D8N+H]+

93.1
[C7H4D2+H]+

Pipette spray performed well in quantitation of antimicrobials in whole milk. Figure
4.11 provided calibration curves of cloxacillin [(M-H)-, m/z 434.20; product ions, m/z
293.00] in the negative ion mode and lincomycin [(M+H)+, m/z 407.22; product ions, m/z
359.20] in the positive ion mode. The x-axis and the y-axis of calibration curves were the
drug concentration in whole milk and the absolute intensity of product ions dissociated
from target precursor ions, respectively. Preliminary experiments showed that the MS
result changed with the presence or absence of the food matrix. Thus, matrix-matched
calibration curves were established to compensate for the suppression from matrix effect.
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A series of working standard solutions were prepared at different concentrations (0, 1.0,
5.0, 10.0, 50.0, 100.0, 500.0, and 1000.0 μg/kg) by gradual dilution with the whole milk.
The quantitation was performed in the single reaction monitoring (SRM) mode by a TSQ
Quantum Access Max mass spectrometer. The linear regression coefficients of the present
calibration curves (R2 > 0.99) demonstrated a good linear relationship over 3 orders of
magnitude in concentration. The sample in each concentration was tested for 3 replicates.
Quantitation of other antimicrobials, including marbofloxacin, difloxacin, and
chlortetracycline in whole milk were also characterized in a similar fashion and reported
in Table 4.2. The above result suggested that the pipette spray has a great potential in quick
estimation of antimicrobials’ concentrations. The quantitative performance of pipette spray
can be enhanced by using internal standard as a reference when necessary.

Figure 4.11 Linear dynamic ranges of whole milk samples obtained for cloxacillin [(MH)-, m/z 434.20; product ions, m/z 293.00] in the negative ion mode and lincomycin
[(M+H)+, m/z 407.22; product ions, m/z 359.20] in the positive ion mode.
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Table 4.2 The comparison between LOQs of pipette spray to the maximum residue levels
(MRL) in council regulation (EEC) No. 2377/90.
Antimicrobial
Family

Analyte

MRL
(μg/kg)

LOQ
(μg/kg)

Quinolone

Marbofloxacin

75

10.0

Difloxacin

N/A

10.0

Macrolides

Lincomycin

100

8.0

Beta-lectams

Cloxacillin

30

10.0

Tetracycline

Chlortetracycline

200

10.0

4.4

Conclusion

In this study, a very sensitive ionization cartridge, pipette spray, was developed by
integrating the paper-based extraction function with the nano-ESI ion source for direct
identification and quantitation of drugs in complex biofluids. The cartridge design
facilitates the fabrication and the usage, so that extraction and ionization of analytes can be
simply accomplished by sequentially applying 1-10 μL biological sample, 10 μL solvent,
and 1.5 kV high voltage on the paper substrate within 1 minute. The importance of the
paper substrate was well demonstrated in decreasing matrix effect. Furthermore, internal
standards can be preloaded in accurately confined area on the paper substrate, so that
excellent LOQ as low as 0.5 ng/mL was achieved for analyzing methamphetamine in the
whole blood with a good precision (RSD<10%). The spray time can achieve to 40 minutes
in very stable signal intensity that suggested reliable and stable results for the quantitative
analysis. The robustness of this method has been demonstrated for antimicrobial
monitoring in milk, which is in great need of fast and reliable quantitative analysis platform
for protecting human health.
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PROFILING UNSATURATED LIPIDS IN TISSUE USING REACTIVE
EXTRACTION SPRAY MASS SPECTROMETRY

5.1

Introduction

Lipids are a group of naturally occurring molecules that display emergent physicchemical properties in cell membrane development, energy production and storage,
hormone production, protection of membrane proteins in hydrophobic environment, and
cellular signaling process through their self-assembly and collective behaviors.1
Unsaturation of lipids, viz. the number and locations of C=C bonds, as an important
parameter for the shape of a lipid, is closely related to the biological function and the
disease state of a tissue by affecting the cell membrane curvature in the context of
membrane permeability, trans-membrane structure, and enzymatic action.2 For example,
the ordering within a membrane is found to be weakest when the C=C bond is located in
the middle of an acyl chain, which enhances the fluidity of the membrane.3 In addition, the
omega-3 fatty acids, containing 18-22 carbons with a signature C=C bond poisoned in the
third place from the methyl end of a lipid, are found to be important in brain development
and cardio-protective functions in both primary and secondary coronary heart disease
preventions trails.4 However, the localization of C=C bonds is still a big challenge in
requiring reliable analytical platforms to profile molecular structures for distinguishing
isomers of a lipid from many possibilities.
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Mass spectrometry (MS) has a great advantage of providing abundant molecular
information with extremely high sensitivity, selectivity, and broad mass range and thus has
been widely used in identification and quantitation of individual lipids. A series of MSbased methods have been developed for determination of C=C bonds either through direct
fragmentation of lipids by high energy collisional-induced dissociation (CID) or through
chemical derivatization before the tandem MS analysis.5 Typically, lipids needs to be
extracted, separated, and purified in several steps before MS analysis, which may require
intensive labor work for up to one day.6 This type of multi-step procedure works well for
analysis of large batches of samples. Meanwhile, ambient ionization mass spectrometry as
a single-step based strategy has shown good performance in analyzing target analytes.
In ambient ionization mass spectrometry, analytes are directly ionized from a sample
in its native state and transferred into the gas phase for MS analysis without or with minimal
sample preparation.7 Many ambient ionization methods have been developed and applied
in direct lipid analysis, such as desorption electrospray ionization mass spectrometry
(DESI),8 matrix-assisted secondary ion mass spectrometry,9 probe electrospray ionization
(PESI),10 matrix-assisted laser desorption electrospray ionization (MALDESI),11 easy
ambient sonic-spray ionization (EASI),12 atmospheric pressure infrared matrix-assisted
laser desorption ionization (AP IR-MALDI),13 paper spray,14 as well as needle biopsy and
spray ionization.15 Some of them can also achieve two-dimensional imaging of lipids on
tissues.16 The application of ambient ionization mass spectrometry in determining double
bond positions was first achieved in microbial fatty acid ethyl ester mixtures from bacterial
samples by low temperature plasma ionization mass spectrometry (LTP-MS).17 However,
little headway has been made in direct localization of double bonds in tissue samples. At
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the same time, although distributions of lipid concentrations have been well profiled in
high resolutions by many powerful imaging platforms,16b,

18

the relationship between

proportions of isomeric lipids among regions of a tissue is still not clear.
In this study, isomeric structures of unsaturated lipids from tissue samples, to the best
of the authors’ knowledge, were first directly determined with systematic structure profiles
using ambient mass spectrometry, which was implemented by extraction spray and on-line
Paternò–Büchi (PB) reaction. The spatial distributions of isomeric ratio of lipids were also
first imaged in the rat brain and kidney.

5.2

Materials and instrumentation

Acetonitrile (ACN), acetone, methanol (MeOH), ammonia (NH3), isopropanol (IPA),
ethanol (EtOH), and formic acid (HPLC-grade) were obtained from Mallinckrodt Baker
(Phillipsburg, NJ, USA). Deionized water was produced by a Millipore Ultrapure Water
Purifier (Billerica, MA, USA). Rats were obtained from Harlan Laboratory (Indianapolis,
IN, USA) and decapitated upon cessation of respiration. The low-pressure mercury lamp
with 254 nm of UV light was purchased from BHK Inc. (BHK Inc., Ontario, CA).
The design and the procedure were shown in Figure 5.1. Lipids were directly extracted
by sticking a stainless steel wire (200 μm o.d.) into a chunk tissue and then immersing into
a nano-ESI capillary preloaded with solvent for extraction and reaction. A high voltage
(DC, 1.8 kV) was applied on the wire to generate electrospray at the nano-ESI tip. A lowpressure mercury lamp with 254 nm of UV light was used to facilitate the PB reaction for
the formation of reaction product ions (+58Da) adding with an oxetane ring at the original
location of the C=C bond, which is subsequently cleaved by the collision induced
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dissociation (CID) to produce characteristic fragment ions (Figure 5.1 B). All the mass
spectra were recorded by a QTRAP 4000 triple quadrupole/linear ion trap hybrid mass
spectrometer (Applied Biosystems/Sciex, Toronto, Canada) with instrument settings as
following: curtain gas, 8 psi; declustering potential, ±20V; interface temperature heater, 40
0

C; and scan rate, 1000 Da/s with the use of Q3 as a linear ion trap. Identification of lipids

was performed by comparing the tandem MS spectra patterns with reported literatures.

5.3

Results and discussion

Lipids are essential to normal cell functions. Lipid profiling therefore has been
increasingly used as phenotypic signals to help biomarker discovery and better
understanding of tissue pathology. Direct tissue analysis by MS with simple procedures is
a key step in accelerating lipidomic analysis, especially for the study of unsaturation of
isomeric lipids. In this chapter, a direct profiling of unsaturated lipids on tissue was
developed using reactive extraction spray. Lipids were directly extracted by a sampling
probe in a nano-ESI capillary for direct ESI-MS analysis. The C=C bond locations can be
easily interpreted based on tandem mass spectra of PB reaction product ions under a UV
light (λ=254 nm). Since the sample consumption of the present method has achieved as
low as 10 μg/sample, distribution of isomeric unsaturated lipids was first profiled on the
rat brain and kidney. The following discussion will focus on four topics: (1) Direct sample
collection, extraction, and ionization of lipids by extraction spray, (2) Direct identification
of lipid C=C location isomers from tissues by PB reaction, (3) Profiling spatial distribution
of lipid C=C location isomeric ratios, and (4) Cross-tissue analysis of phospholipids C=C
location isomers.
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Figure 5.1 Schematic overview of direct identifying C=C bond positions of lipids in
tissues with combination of extraction spray and PB reaction. (A) Tissue sampling by a
stainless steel probe (200 μm o.d.) and in-capillary extraction of lipids with subsequent MS
analysis by nano-ESI and UV light (λ=254 nm). (B) PB reaction between acetone and fatty
acid in association with possible fingerprint fragment ions in retro PB reaction for
localizing double bond positions.

5.3.1

Direct lipid collection, extraction, and ionization from tissues

Typically, lipid extraction from the tissue sample is the first step for the shot-gun
lipidomic analysis. The traditional protocol for lipid extraction is based on the overnight
liquid-liquid extraction principle after homogenization of solid tissues. Therefore, the
development of extraction spray can significantly simplify and accelerate the shot-gun
lipidomics by direct lipid extraction from tissue.
Lipids were extracted from rat tissues consisting of brain, kidney, and liver. These
tissues were removed from the rat bodies and immediately frozen at -80oC. All the surgeries
were performed in accordance with the Purdue University Animal Care and Use
Committee guidelines and ARRIVE guidelines. Before the lipid extraction, tissues were
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gradually thaw in a -20oC freezer and then in a 4oC for 1 hour, respectively. The tissues
were then transferred onto a glass slide and stored in an ice box for the experimental use.
The extraction spray was implemented for the direct analysis of tissue as shown in Figure
5.1. Using a procedure similar to tissue biopsy, a stainless steel wire (200 μm o.d.) was
inserted into a tissue at a depth of ~2 mm, and then immersed into 20 µL solvent in a glass
capillary (1.5 mm o.d. and 0.86 mm i.d.) with a pulled tip for nano-ESI. The solvent was
prepared as acetone/acetonitrile/water (v/v/v=70/20/10) for phospholipids, while
acetone/water (v/v=70/30) for fatty acids. The sampled lipids were then transferred into
the solvent and a 1.8 kV DC was applied on the wire to generate electrospray.
(A)

(B)
))

Figure 5.2 (A) Full MS scan of lipid extracts of rat brain, kidney, and liver by extraction
spray. (B) MS/MS of PS 18:0-18:1 extracted from rat brain for structural identification.
Tissue sampling by a stainless steel probe (200 μm o.d.) and in-capillary extraction of lipids
with subsequent nano-ESI-MS analysis.
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The extraction process of lipids from tissue has been shown to be very efficient by
extraction spray, as demonstrated in Figure 4.2 including rat brain, kidney, and liver tissues,
respectively. Fatty acids and phospholipids quickly appeared in the mass range from m/z 200
to 900, and reached an equilibrium of intensity within 20s when a high voltage was applied
to the nano-ESI. A good reliability of lipid extraction was also proven for similar MS peak
patterns as spectra of conventional lipid extracts. Meanwhile, the MS peak patterns differ
with diverse types of tissues. The head group and acyl chains of each phospholipid or lysophospholipid can be easily identified by tandem mass spectrometry (Figure 5.2 B). The
selection of organic solvent was critical to the sensitivity of the lipid analysis. Hydrophobic
organic solvents, such as DMSO, dichloromethane, MeOH, and ACN, can extract lipids with
very high efficiency, but some of them may kill the electrospray like dichloromethane and
DMSO. As shown in Figure 5.3 A-B, five formulations of solvents were tested to optimize
the extraction and ionization efficiency of the extraction spray. Since acetone is the reagent
of the PB reaction, it was used as the major solvent (70% in volume) to enhance the PB
reaction. H2O was added with 10% in volume for improving the PB reaction efficiency and
the electrospray stability. EtOH and IPA were found to achieve the highest signal intensity
of fatty acid (FA) 18:1 and phosphatidylserine (PS) 36:1, respectively, due to increased
solubility of lipids. This enhancement was particularly significant for phospholipids that
cannot be effectively extracted only by acetone-water solution (Figure 5.3 C-E) Considering
the reaction efficiency, however, the formulation was further optimized with the PB reaction.
The result will be discussed in the following section.
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(A)

(B)

(C)

(D)

(E)

Figure 5.3 Optimization of solvents for lipid extraction. Effect of solvent on the signal
intensity of (A) FA 18:1 [(M-H)-, m/z 281.3] and (B) PS 36:1 [(M-H)-, m/z 788.5] directly
extracted from rat brain tissue by extraction spray. MS spectrum of lipids directly extracted
in a formulation with 70% acetone+10% H2O+20% solvent X, X= (C) H2O, (D) IPA, and
(E) ACN. Tissue sampling by a stainless steel probe (200 μm o.d.) and in-capillary extraction
of lipids with subsequent nano-ESI-MS analysis. Voltage: 1.8 kV.
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5.3.2

Direct identification of lipid C=C location isomers from tissues by Paternò–Büchi
reaction

In order to locate individual double bond positions in each acyl chain of a lipid, PB
reaction was performed with a low-pressure mercury lamp orthogonally positioned to the
nano-ESI tip in a distance of 0.5-1.0 cm. The wavelength of the UV lamp was 254 nm for
exciting acetone into radicals. All the mass spectra were recorded by a QTrap 4000 triple
quadrupole/linear ion trap hybrid mass spectrometer. For locating C=C bonds on
unsaturated fatty acids by tandem mass spectrometry, their PB reaction products were
isolated by Q1 quadrupole array and then were transferred to Q3 linear ion trap for onresonance activation (ion-trap CID). The excitation energy (AF2) was set in the range of
30-70 V in accordance of each fatty acid. For unsaturated phospholipids, lipids or their PB
reaction products were isolated by Q1 quadrupole array and then were accelerated to q2
quadrupole array for beam-type CID. The collision energy (CE) varied from 25 to 50 V in
different molecular species. The determination of C=C locations of phospholipids was
according to the MS3 mass spectra, in which the cleaved unsaturated acyl chains of PB
product ions were selected for further fragmentation in the Q3 linear ion trap by applying
AF2 of 30-70 V. Identification of lipids was performed by comparing the tandem MS
spectra patterns with reported literatures.
As shown in Figure 5.4 A-B, intensities of unsaturated fatty acids or phospholipids
significantly decreased while many new peaks as product ions of PB reactions appeared
after radiation under the UV light. Double bond positions were indicated according to
fingerprint fragments which were derived from retro PB reaction by CID in an ion trap
mass spectrometry. The MS2 CID mass spectrum of m/z 339.3, as the product ions of fatty
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acid (FA) 18:1 in PB reaction, was shown in Figure 5.4 C. Double bonds were designated
to position in the ninth (Δ9) or eleventh (Δ11) carbon from the carboxyl terminal of the
lipid, respectively, based on two pairs of new generated fragments at m/z 171.0 & m/z 197.1,
as well as m/z 199.0 and m/z 225.1 in comparison of MS2 spectra before and after PB
reaction..

Figure 5.4 Direct lipid analysis with combination of on-line PB reaction and extraction
spray mass spectrometry. Mass spectrum of lipids sampling from the rat kidney by
extraction spray in negative ion mode before (A) and after (B) PB reaction induced by UV
irradiation. (C) MS2 CID of the PB reaction products at m/z 339.3 for determination of
double bonds of FA 18:1 (m/z 171 and m/z 197 for Δ9; m/z 199 and m/z 225 for Δ11) in
kidney. Tissue sampling by a stainless steel probe (200 μm o.d.) and in-capillary extraction
of lipids with subsequent nano-ESI-MS analysis. Voltage: 1.8 kV.
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For localization of C=C bonds in phospholipids, take PS 18:0-18:1 (parent ion: 788.3)
as an example, the same result was also obtained in the acyl chain 18:1 based on the MS3
CID fragments derived from cleaved unsaturated acyl chains of PB reaction product ions
(Figure 5.5)

(A)

(B)

Figure 5.5 Direct lipid analysis with combination of on-line PB reaction and extraction
spray mass spectrometry. (A) MS2 CID of PS 18:0-18:1 at m/z 778.5 for identifying the
head group (m/z 701.4 for PS) and the length of acyl chains (m/z 281 for FA 18:1; m/z 283
for FA 18:0). (E) MS3 CID of m/z 339.4 from P-B reaction product of PS 18:0-18:1 (m/z
171 and 197 for Δ9; m/z 199 and 225 for Δ11). Tissue sampling by a stainless steel probe
(200 μm o.d.) and in-capillary extraction of lipids with subsequent nano-ESI-MS analysis.
Voltage: 1.8 kV.
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(B)

(A)

(E)

(C)

H2O

H2O

(D)

H2O

Figure 5.6 Optimization of reaction conditions for PB reaction of lipids and acetone.
Effect of lamp condition to the reaction kinetics of PB reaction of FA 18:1 [(M-H)-, m/z
281.3; reaction product ions, m/z 339.3] and acetone (A) with or (B) without pre-heating
the UV lamp (λ=254 nm). Effect of solvent on (C) reaction time and reaction yields of (D)
FA 18:1 and (E) PS 18:0-18:1 [(M-H)-, m/z 788.5, reaction product ion, m/z 339.3]. Tissue
sampling by a stainless steel probe (200 μm o.d.) and in-capillary extraction of lipids with
subsequent nano-ESI-MS analysis. Voltage: 1.8 kV.

155
As discussed above, the addition of alcohols and ACN significantly improved the
extraction efficiency of phospholipids, however, the yields of PB reaction products were
decayed in varying degrees due to the UV absorption of alcohols or ACN to form radicals
in the wavelength similar to 254 nm. Since ACN's UV absorption wavelength was the
furthest away from the wavelength of 254 nm, its interference to the PB reaction was lowest
(Figure 5.6 C-E). Solvents of 70% acetone:30% H2O (v:v) as well as 70% acetone:20%
ACN:10% H2O (v:v:v) were found to provide the optimal performance for the analysis of
fatty acids and phospholipids, respectively. Furthermore, interestingly, the half growth
time of PB reaction products was accelerated from 1.5 minutes to 0.5 minutes by preheating the lamp because pre-heating could help the lamp to quickly achieve the optimum
condition of the light intensity and the wavelength (Figure 5.6 A-B). The reactive
extraction spray showed its good performance in analyzing unsaturated lipids in a broad
dynamic range of concentrations. Eight unsaturated fatty acids (Table 5.2) and twentythree unsaturated phospholipids (Table 5.1) in concentrations across three orders of
magnitudes in the rat brain were analyzed with good reproducibility of isomeric ratios
(RSD<10%, sampling in the same region of one tissue, N=3). In addition, unsaturated
lipids in trace level can also be analyzed with good signal-to-noise ratios. The lowest
abundance of lipids, as 0.34% of total fatty acids for FA 19:1 and 0.0013% of total lipids
for phosphatidylglycerol (PG) 34:2, have been achieved in direct analysis of rat brain.
Figure 5.7 C and D showed typical tandem mass spectra of FA 19:1 and PG 34:2 for
determination of double bond locations after PB reaction. Two possible positions (Δ9 and
Δ11) of FA 19:1 and two possible positions (Δ9 and Δ11) were found according to
fingerprint peaks m/z 171.0 & 197.0 for Δ9 and m/z 199.1 & 225.1 for Δ11, respectively.
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Table 5.1

List of unsaturated phospholipids identified.

Molecular
Name

m/z before & after
P-B reaction
Before

After

Distribution of
Phospholipids in
Brain

LPA 18:1
cLPA 18:1

435.3
417.2

493.3
475.2

LPG 18:1

509.3

567.3

LPI 18:1
LPE 18:1
PA 18:1-18:1
PA 18:2-18:0
PA 18:0-18:1
PA 16:0-18:1
PA 16:1-18:0
PS (18:1)-16:1
PS 18:1-(16:1)
PS 18:1-16:0
PS 18:1-18:0
PS 18:1-18:1
PS 18:2-18:0
PS (20:1)-18:1
PS 20:1-(18:1)
PS 20:0-18:1
PS 20:1-18:0
PI 18:0-18:1
PI 18:1-18:1
PG 18:0-18:1

597.3
480.3

655.3
538.3

1.75±0.38 nmol/g
N/A
1.70±0.06 pmol in
serum
5.0±2.2 nmol/g
0.026%±0.002%

699.4

757.4

0.047%±0.002%

701.4

759.4

0.111%±0.004%

673.4

731.4

0.126%±0.007%

758.4

816.4

0.002%±0.000%

760.3
788.5

818.3
846.5

0.065%±0.005%
0.556%±0.018%

786.5

844.5

0.144%±0.011%

814.5

872.5

0.030%±0.002%

816.5

874.5

N/A

863.3
861.3
775.5

921.3
919.3
833.5

773.5

831.5

0.125%±0.002%
0.025%±0.001%
0.0090%±
0.0005%
0.0152%±
0.0004%

745.5

803.5

0.0013%±
0.0001%

744.5

802.5

0.405%±0.011%

742.5

800.5

0.248%±0.008%

PG 18:1-18:1
PG 18:2-18:0
PG (18:1)-16:1
PG 18:1-(16:1)
PG 18:2-16:0
PE 18:0-18:1
PE 18:1-18:1
PE 18:2-18:0

Table 5.2
Molecular
Name

Isomeric
Isomeric
Ratio in
Ratio in
Prefrontal Brain Stem
Cortex (right)
(Δ9 / Δ11)
(Δ9 / Δ11)

Isomers
(n=3)

Δ9
Δ9

Δ11
Δ11

5.4±0.4
2.2±0.04

4.6±0.3
1.7±0.02

Δ9

Δ11

2.1±0.2

1.4±0.04

Δ9
Δ9
Δ9
Δ9
Δ9
Δ9
Δ9
Δ9
Δ9
Δ9
Δ9
Δ9
N/A
Δ9
Δ9
Δ9
Δ9
Δ9
Δ9
Δ9

Δ11
Δ11
Δ11
Δ11
Δ11
Δ11

2.4±0.1
3.2±0.3
4.7±0.3

2.3±0.04
1.8±0.2
2.3±0.06

6.8±0.2
3.0±0.1

8.4±0.3
2.6±0.1

Δ11

3.7±0.04

3.1±0.1

Δ11
Δ11
Δ11

4.6±0.01
11.5±0.5
5.3±0.2

3.9±0.2
9.5±0.8
3.1±0.1

Δ11
Δ11
Δ11
Δ11
Δ11
Δ11
Δ11

2.3±0.2
3.4±0.1
4.4±0.2
5.3±0.6
3.0±0.3
2.2±0.2

2.5±0.1
1.7±0.04
3.0±0.04
7.9±0.2
1.9±0.1
1.7±0.04

1.2±0.03

1.7±0.1

Δ9
N/A
Δ9
Δ11
N/A
Δ9
Δ9
N/A

Δ11

3.1±0.1

2.1±0.2

Δ11

2.7±0.2

2.4±0.2

Δ11
Δ11

3.4±0.01
4.8±0.1

3.2±0.01
2.9±0.1

List of unsaturated fatty acids identified.
m/z before &
after P-B
reaction
Before After

FA 16:1

253.2

311.2

FA 18:2
FA 18:1
FA 19:1
FA 20:1
FA 20:4
FA 22:1
FA 24:1

279.3
281.3
295.3
309.4
311.3
337.4
365.4

337.3
339.3
353.3
367.4
369.4
395.4
423.4

Distribution
of Fatty
Acids in
Brain

3.53%
81.87%
0.34%
4.42%
0.47%
5.20%

Isomeric Ratio
Isomeric Ratio
in Prefrontal
in Brain Stem
Cortex (right)
(left / right)
(left / right)

Isomers (n=3)

Δ9
Δ9
Δ9
Δ9
Δ11
Δ5
Δ9
Δ11

Δ11
Δ11
Δ11
Δ13
Δ8
Δ11
Δ15

2.8±0.06
1.2±0.04
1.5±0.03
Δ11
Δ13
Δ17

2.4±0.1
0.8±0.05
1.6±0.1

Δ14
58.3/18.6/ 23.1 37.9/20.0/42.1
12.2/45.3/42.4 15.9/31.6/52.6
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Figure 5.7 Dynamic range of lipids analyzed. (A) Molar percentages of identified fatty
acids of total fatty acids. (B) Molar percentages of identified phospholipids of total lipids.
(C) MS2 CID spectra of FA 19:1 at m/z 353.1 (m/z 171.0 and m/z 197.0 for Δ9; m/z 199.1
and m/z 225.1 for Δ11) and (D) MS3 CID spectra of PG 34:2 at m/z 339.3 in rat brain for
determination of double bond positions (m/z 171.0 and m/z 197.0 for 18:1(Δ9); m/z 199.1
and m/z 225.1 for 18:1(Δ11)).

5.3.3

Profiling spatial distribution of lipid C=C location isomeric ratios

Benefiting from noteworthy advantages of small sampling area (0.04 cm2) and low
sample consumption (~10 μg) of extraction spray, isomeric ratios of unsaturated lipids have
also been first mapped for the rat brain and kidney. To perform the two-dimensional
imaging, an intact rat brain or a dissected kidney was positioned on a piece of graph paper
in a resolution of 500 μm. A sampling probe was then inserted into the tissue with a precise
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coordinate position in a depth of approximately 2 mm. Each region was sampled at 1-3
locations with 3 duplicates at each location to obtain a representative isomeric ratio.
Phosphatic acid (PA) 18:1-18:1, lysophosphatic acid (LPA) 18:1 and FA 18:1 were
selected as target molecules due to their well-known messenger functions and their close
relationship in molecular synthesis coordinated by glycerol-3-phosphate acyltransferase or
lysophosphatic acyltransferase.19 For rat brain imaging, the above three lipids in 14
selected anatomical regions, including spinal cord, brain stem, cerebellum, paraflocculus
(left and right), inferior colliculus (left and right), pineal gland, parietal cortex (left and
right), moor cortex (left and right), and olfactory (left and right), were symmetrically
identified and quantitatively mapped (Figure 5.8).

Figure 5.8 Two-dimensional isomeric ratio (±SD, N=3) images of lipids in rat brain and
kidney by reactive extraction spray mass spectrometry in negative ion mode. Twodimensional isomeric ratio images of FA 18:1 (Δ9 to Δ11) distributed in (A) intact rat
brains and (B) kidneys. Two-dimensional isomeric ratio (±SD, n=3) images of (C) LPA
18:1 (Δ9 to Δ11) and (D) PA 18:1-18:1 (Δ9 to Δ11) distributed in an intact rat brain.
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A more comprehensive map of PA 18:1-18:1 were provided with isomeric ratios in 26
regions of rat brain as shown in Figure 5.9 C. Profiting from small sample consumption,
the brain was kept in good condition after it was sampled for 50 times (Figure 5.9 D).
Interestingly, significant differences in isomeric ratios of LPA 18:1 and PA 18:1-18:1 were
observed in different regions of the rat brain, while the isomeric ratio of FA 18:1 was
relatively stable in both rat brain and kidney under investigation. This result indicate that
the selection of isomeric FA 18:1 for synthesis of PA 18:1-18:1 and LPA 18:1 is possibly
not a random process and may be closely related to regions of a tissue. Although the
mechanism is not clear, the present platform brings a big potential to reveal the selective
synthesis of isomeric phospholipids and also provides a supportive platform to understand
the effect of unsaturation of lipids on the function of a tissue.

Figure 5.9 Schematic representation of functional regions of (A) rat brain in dorsal aspect
and (B) rat kidney section. (C) Two-dimensional isomeric ratio (±SD, N=3-9) image of PA
18:1-18:1 (Δ9 Vs. Δ11) in rat brain. (D) Photos of rat brain before and after sampling for
50 times.
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In addition, distinctive isomeric ratios of 39 lipids were different in various degrees
between the right prefrontal cortex and brain stem of the same rat brain, which is possibly
related to the brain functions and required further study to explain these differences.

(A)

(B)

9,12

11Vs.15Vs.17
5,8,11,14
9 Vs.11
9Vs.11Vs.13
11Vs.13

9,12

11Vs.15Vs.17
5,8,11,14
9 Vs.11
9Vs.11Vs.13
11Vs.13

9 Vs.11
9

9 Vs.11
9

Figure 5.10 Unsaturation of (A) phospholipids and (B) fatty acids in prefrontal cortex
and brain stem of rat brain.

5.3.4

Cross-tissue analysis of phospholipids C=C location isomers

A good consistency in isomeric ratio distribution of PA 18:1-18:1 was demonstrated
as their RSDs were all below 21% when comparing among six selected anatomy regions
of five brains in a similar condition but from different batches (Figure 5.11 A). This
consistency further suggested that the synthesis of PA 18:1-18:1 from FA 18:1 was
regulated under a relative constant ratio of C=C location isomeric lipids. The reactive
extraction spray mass spectrometry provides a reliable analytical platform to reveal the
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potential effects of isomeric ratios on the biological functions of the brain. In addition, the
effect of sample storage on unsaturation of lipids were also investigated by comparing
isomeric ratios of PA 18:1-18:1 between three fresh rat brains and another three frozen in
-20 oC for 14 days (Figure 5.11 B). Six regions of rat brains were selected including inferior
colliculus (left and right), motor cortex (left and right), cerebellum and brain stem. Stable
and consistent unsaturation of PA 18:1-18:1 were demonstrated when the sample were
frozen in -20 oC in a short time.

(A)

(B)

Figure 5.11 (A) Isomeric ratios (±SD, N=5) of PA 18:1-18:1 (Δ9 to Δ11) in six regions
of five rat brains, including inferior colliculus (left and right), moter cortex (left and right),
cerebellum, and brain stem. (B) Impact of frozen and thaw on unsaturation of lipids.
Isomeric ratios (Δ9/Δ11) of PA 18:1-18:1 in the same six anatomy regions of fresh rat
brains and thawed brains frozen in -20 oC for 14 days.
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5.4

Conclusion

Direct tissue analysis by mass spectrometry (MS) with simple procedures is a key step
in accelerating lipidomic analysis, especially for the study of unsaturation of isomeric lipids.
In this study, isomeric structures of unsaturated lipids from tissues, to the best of the authors’
knowledge, were first directly determined with systematic structure profiles in a single step
by ambient mass spectrometry, which was implemented by on-line PB reaction and
extraction spray mass spectrometry. Lipids were directly extracted by sticking a stainless
steel wire into a chunk tissue and then immersing into a nano-ESI capillary preloaded with
solvent for extraction, reaction and detection by ESI-MS. UV light (λ=254 nm) was used
to facilitate the PB reaction to form reaction product ions (+58Da) added with an oxetane
ring at the original location of the C=C bond, which was subsequently cleaved by CID to
produce characteristic fragment ions. The unsaturation of lipids in a broad dynamic range
of concentrations (0.0013%-0.5% of total lipids in rat brain) can be identified with good
reproducibility (isomeric ratios of lipids detected: RSD<10%, sampling in the same region
of one tissue; RSD<21%, sampling in the same region of tissues in the same type). Since
the sample consumption of the present method has achieved as low as 10 μg/sample, the
distribution of isomeric unsaturated lipids was first profiled on the rat brain and kidney.
Significant differences in isomeric ratios of lysophosphatic acid (LPA) 18:1 and phosphatic
acid (PA) 18:1-18:1 were observed in different regions of the rat brain, while isomeric
ratios of fatty acid (FA) 18:1 was relatively stable in both rat brain and kidney.
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